CURRICULUM VITAE
RICHARD SCOTT FOSTER
Indiana University School of Medicine
Department of Urology
535 N. Barnhill Dr., #420
Indianapolis, IN 46202-5289
(317) 274-3458
PERSONAL DATA:
DATE OF BIRTH:
April 10, 1954
PLACE OF BIRTH:
Corydon, Indiana
MARITAL/FAMILY STATUS:
CHILDREN:
Natalie Kathleen
Abby Elizabeth
Hannah Nicole
EDUCATION/TRAINING:
1976
1980
1980-1982
1982-1986
Married Kathy Jean Hungness
September 17, 1983
`
Miami University, A.B., Cum Laude
Indiana University Medical School, M.D.
Surgical Intern/Resident, Indiana University Hospitals
Urology Resident, Indiana University Hospitals
ACADEMIC HONORS/AWARDS:
1972
1972
1972
1973
1973
1976
2005
Indiana State Scholarship
Chauncey Rose Scholarship, Rose-Hulman Institute
of Technology
W.R. and Elsi Krickenberger Scholarship, Miami University
Phi Eta Sigma Honorary Society
Indianapolis Alumni Club Scholarship, Miami University
Phi Beta Kappa Honorary Society
Trustee Teaching Award
LICENSURE:
Licensed in Indiana
ACADEMIC APPOINTMENTS:
1998-Present
1992-1998
1986-1992
Professor, Department of Urology
Indiana University School of Medicine
Associate Professor, Department of Urology
Indiana University School of Medicine
Assistant Professor, Department of Urology
Indiana University School of Medicine
MEMBERSHIPS IN SOCIETIES:
Member, American Urological Association
Member, The Society of University Urologists
Member, Eastern Cooperative Oncology Group;
Chairman, Testis Cancer Subcommittee
Member, North Central Section of the American Urological Association
Fellow, American College of Surgeons
Member, Hoosier Oncology Group;
Co-Chairman, GU/GYN Committee
Member, WHO Committee on Nonmedical & Nonsurgical Alternative
Treatments of BPH
Member, Society of Urologic Oncology
Member, Societe Internationale d'Urologie
Member, Society of Surgical Oncology
Corresponding Member, European Association of Urology
Member,
American
Society
of
Clinical
Oncology;
GU
Cancer
Subcommittee
of the ASCO 2000-2001 Program Committee
CERTIFICATION:
Board Certified, American Board of Urology, 1988
Board Recertified, American Board of Urology, 1997
Board Recertified, American Board of Urology, 2007
SERVICE:
Director of Student Teaching, Urology Department, 1986-1996
Reviewer, Journal of Urology
Reviewer, Journal of Clinical Oncology
Reviewer, Urology
Reviewer, Medical Research Council Grants
Reviewer, Southern Medical Journal
Reviewer, Journal of Pediatric Surgery
Editorial Comments, Yearbook of Urology, 1996
Member, Thesis Review Committee, Teresa Smolarek & Ruth Blough,
Dept. of Medical Genetics
Reviewer, American Journal of Clinical Pathology
2
Reviewer, Expert Review of Anticancer Therapy
Reviewer, Gynecologic Oncology
Member, Program Committee, AUA Annual Meeting, San Francisco, CA,
May, 2004.
University Committee Service
Radiation Therapy Search Committee, VA Hospital, 1988
Nephrology/Urology Topic Committee, 1989-1990
Credentials Committee, 1989-1992
Research & Development Committee, VA Hospital, 1989-1993
Course Directors Committee, 1989-1996
Conscious Sedation Committee, 1991-1993
Cancer Committee, University Hospital, 1991-1998
Co-Chairman, GU Section, Planning grant for Indiana University
Comprehensive Cancer Center
Ad Hoc Laser Committee, 1994-1998
Cancer Committee, VA Hospital, 1994-1996
Education & Curriculum Committee, 1994-1996
Ambulatory Care Committee, 1995-1996
University Hospital O.R. Subteam, 2003-2004.
PUBLICATIONS:
Salmonella Enteritidis:
Testicular Abscess in a Newborn.
Weber, Kleiman, Grosfeld. Journal of Urology,130:790, 1983.
False-Positive DTPA Scans in Children.
Pediatric Urology Newsletter, 1984.
Congenital Posterior Urethral Polyps.
Journal of Urology, 136:670, 1986.
Foster,
Foster, R. and Mitchell, M.
Foster, R.S. and Garrett, R.A.
Vesical Endometriosis:
Medical or Surgical Treatment? Foster, R.S.,
Rink, R. and Mulcahy, J.J.
Urology,Vol. XXIX, No. 1, p. 64-65,
January, 1987.
Prevention
of
Postprostatectomy
Vesical
Neck
Contracture
by
Prophylactic Vesical Neck Incision.
Kulb, T.B., Kamer, M.,
Lingeman, J.E. and Foster, R.S.
Journal of Urology, Vol. 137, No.
2, p. 230, February, 1987.
Retroperitoneal Fibrosis and Nonmalignant Ileal Carcinoid. Scott, J.,
Foster, R.S. and Moore, A. Journal of Urology, 138:1435, May, 1987.
Focal Salmonella Enteritidis Infection of Urinary Tract. Foster, R.S.,
Rink, R.C. and Mulcahy, J.J.
Urology, Vol. XXIX, No. 6, p. 646,
June, 1987.
Testicular Papillary Cystadenomatous Tumor of Low Malignant Potential:
3
A Case Report and Discussion of the Literature. Brito, C.G., Bloch,
T., Foster, R.S. and Bihrle, R. Journal of Urology, 139:378, 1988.
Use of a Caval-Atrial Shunt for Resection of a Caval Tumor Thrombus in
Renal Cell Carcinoma.
Foster, R.S., Mahomed, Y., Bihrle, R., and
Strup, S. Journal of Urology, 140:1370, 1988.
Testis Cancer Home Study Course Series XI.
Donohue, J.P., Rowland,
R.G., and Foster, R.S. American Urological Association, 1988.
Neoadjuvant M-VAC in Invasive Bladder Cancer.
Foster, R.S. and
Grimaldi, M.
Hoosier Oncology Group Newsletter, Vol. 2, No. 1,
March, 1989.
Creation
of
Transverse
Colon-Gastric
Composite
Reservoir:
New
Technique.
Bihrle, R., Foster, R.S., Steidle, C.P., Adams, M.C.,
Woodbury, P.W., Sutton, G.P., and McNulty, A.
Journal of Urology,
141:1216, 1989.
Surgical Therapy of Post Chemotherapy Testicular Cancer. Foster, R.S.,
Donohue, J.P., Bihrle, R., and Rowland, R.G. Advances in Oncology,
Vol. 5, No. 3, pp. 22-24, 1989.
Construction of an Antirefluxing Urinary Conduit Using a Plicated
Ileocecal Segment. Bihrle, R., Brito, C.G., Adams, M.C., Woodbury,
P.W., and Foster, R.S. Journal of Urology, 142:1567-1569, 1989.
Nerve-Sparing Preserves Sexual Function. Donohue, J.P., Foster, R.S.,
Jones, J.A. and Geier, G. Contemporary Urology, Vol. 1, No. 6, pp.
41-47, December, 1989.
Anastomotic
Suture
Granuloma
Following
Radical
Retropubic
Prostatectomy.
Scheidler, D.M., Foster, R.S., Bihrle, R., Scott,
J.W., and Litwiller, S.E. Journal of Urology, 143:133-134, 1990.
Use of Magnetic Resonance Imaging to Determine Surgical Approach to
Renal Cell Carcinoma with Vena Caval Extension.
Hockley, N.M.,
Foster, R.S., Bihrle, R., Steidle, C.P., and Kopecky, K.K. Urology,
Vol. XXXVI, No. 1, pp. 55-60, July, 1990.
Ureteral Stump Transitional Cell Carcinoma in a Patient with Recurrent
Superficial
Bladder
Cancer:
An
Argument
for
Complete
Nephroureterectomy in Selected Patients.
Klee, L.W., Adams, M.C.,
and Foster, R.S. Journal of Urology, 144:972, 1990.
Nerve-Sparing Retroperitoneal Lymphadenectomy with Preservation for
Ejaculation.
Donohue, J.P., Foster, R.S., Rowland, R.G., Bihrle,
R., Jones, J.A., and Geier, G.E. Journal of Urology, 144:287-292,
1990.
Role
of
Serum
Prolactin
Determination
in
Evaluation
of
Impotent
4
Patient.
Foster, R.S., Mulcahy, J.J., Callaghan, J.T., Crabtree,
R., and Brashear, D. Urology, 36:499, December, 1990.
Transverse Colon-Gastric Tube Composite Reservoir. Bihrle, R., Klee,
L.W., Adams, M.C., Steidle, C.P. and Foster, R.S.
Urology, 37:36,
January, 1991.
Stage A Nonseminomatous Testis Carcinoma:
Rationale and Results of
Nerve-Sparing
Retroperitoneal
Lymphadenectomy.
Foster,
R.S.,
Donohue, J.P., and Bihrle, R. Urologia Internationalis, 46:294-297,
May, 1991.
The Detection of Serum Antisperm Antibodies in Patients with Primary
Testicular Cancer. Foster, R.S., Rubin, L.R., McNulty, A., Bihrle,
R.,
and
Donohue,
J.P.
International
Journal
of
Andrology,
14:179-185, May, 1991.
Resection of the Inferior Vena Cava or Intraluminal Vena Caval Tumor
Thrombectomy During Retroperitoneal Lymph Node Dissection for
Metastatic Germ Cell Cancer:
Indications and Results.
Donohue,
J.P., Thornhill, J.A., Foster, R.S., Rowland, R.G., and Bihrle, R.
Journal of Urology, 146:346-349, August, 1991.
Early Clinical Experience With the Transverse Colon-Gastric Tube
Continent Urinary Reservoir.
Bihrle, R., Klee, L.W., Adams, M.C.,
and Foster, R.S. Journal of Urology, 146:751-753, September, 1991.
Laparoscopic Spermatic Vein Ligation in Dogs.
Klee, L.W., Brito,
C.G., Bihrle, R., Dreesen, R.G., Canal, D.F., and Foster, R.S.
Journal of Endourology, Vol. 5, No. 4, 1991.
Conversion of an Ileal Conduit to a Continent Catheterizable Stoma.
Adams, M.C., Bihrle, R., Foster, R.S., and Brito, C.G.
Journal of
Urology, 147:126-128, January, 1992.
Laparoscopic Varicocele Ligation. Klee, L.W., Rink, R.C., Bihrle, R.,
and Foster, R.S.
Dialogues in Pediatric Urology, Vol. 15, No. 2,
February, 1992.
Surgical Treatment of Clinical Stage A Nonseminomatous Testis Cancer.
Foster, R.S. and Donohue, J.P.
Seminars in Oncology, Vol. 19, No.
2, pp. 166-170, April, 1992.
Testicular Ultrasonography After Chemotherapy for Germ Cell Neoplasm:
Significance of Highly Hyperechoic Lesions. Kopecky, K.K., Brendle,
M.T., Harman, J.T., Foster, R.S., Bihrle, R., and Loehrer, P.J.
Urology, Vol. 39, No. 5, pp. 490-494, May, 1992.
What's New in Urologic Cancer.
Foster, R.S.
Journal of Urological
Nursing, Vol. 11, No. 2, pp. 77-82, June, 1992.
5
Intra-Abdominal Desmoid Tumor: An Unusual Case of Recurrent Tumor in
a Testis Cancer Patient. Little, J.S. and Foster, R.S. Journal of
Urology, 147:1619-1621, June, 1992.
Nerve-Sparing Retroperitoneal Lymphadenectomy.
Foster, R.S. and
Donohue, J.P.
The Report on Urologic Techniques, Vol. 2, No. 6,
June, 1992.
Hepatic Mobilization:
Useful, Expeditious Maneuver.
Jones, J.A.,
Foster, R.S., and Bihrle, R.
Contemporary Urology, Vol. 4, No. 8,
pp. 49-68, August, 1992.
A
Preliminary
Report:
Postoperative
Fertility
Assessment
in
Nerve-Sparing RPLND Patients. Foster, R.S., Bennett, R.M., Bihrle,
R., and Donohue, J.P. European Journal of Urology, Vol. 23, No. 1,
pp. 165-168, 1993.
Ultrasound Intracavity System for Imaging, Therapy Planning and
Treatment of Focal Disease. Sanghvi, N.T., Foster, R.S., Fry, F.J.,
Bihrle, R., Hennige, C., and Hennige, L.V.
Ultrasonics Symposium
Proceedings 92CH3118-7, p. 1249-1253, 1993.
Transrectal Ablation of Prostate Tissue Using Focused Ultrasound.
Sanghvi, N.T., Foster, R.S., Bihrle, R.,Fry, F.J., Phillips, M., and
Hennige, C. IEEE Ultrasonic Symposium, 1993.
Primary Retroperitoneal Lymph Node Dissection in Clinical Stage A
Nonseminomatous Germ Cell Testis Cancer:
A Review of the Indiana
University Experience (1965-1989).
Donohue, J.P., Thornhill, J.A.,
Foster, R.S., Rowland, R.G., and Bihrle, R.
British Journal of
Urology, 71, 326-335, 1993.
Special Report: High Intensity Focused Ultrasound in the Treatment of
BPH. Bihrle, R., Foster, R.S., Sanghvi, N.T., Fry, F.J. and Regan,
J. Prospectives, Vol. 2, No. 5, pp 6-8, 1993.
Retroperitoneal Lymphadenectomy for Clinical Stage A Testis Cancer
(1965-1989); Modifications of Technique and Impact on Ejaculation.
Donohue, J.P., Thornhill, J.A., Foster, R.S., Rowland, R.G., and
Bihrle, R. Journal of Urology, 149:237-243, 1993.
Production of Prostatic Lesions in Canines Using Transrectally
Administered High Intensity Focused Ultrasound.
Foster, R.S.,
Bihrle, R., Sanghvi, N., Fry, F., Kopecky, K., Regan, J., Eble, J.,
Hennige, C., Hennige, L.V., and Donohue, J.P. Europ. J. Urol. Vol.
23, 2:330-336, 1993.
High-Intensity Focused Ultrasound in the Treatment of Prostatic
Disease.
Foster, R.S., Bihrle, R., Sanghvi, N.T., Fry, F.J., and
Donohue, J.P. Europ. J. Urol. Vol. 23(suppl 1):29-33, 1993.
Percutaneous Access to a Continent Urinary Reservoir for Removal of
6
Intravesical Calculi: A Case Report. Hollensbe, D.W., Foster, R.S.,
Brito, C.G., and Kopecky, K.
Journal of Urology 149:1546-1547,
June, 1993.
Management of Chylous Ascites after Retroperitoneal Lymph Node
Dissection for Testicular Cancer.
Baniel, J., Foster, R.S.,
Rowland, R.G., Bihrle, R., and Donohue, J.P.
Journal of Urology,
150:1422-1424, 1993.
Benign Testicular Tumor Associated with Klinefelter's Syndrome.
Baniel, J., Perez, J.M., and Foster, R.S. Journal of Urology,
151:157-158, 1993.
Retroperitoneal Lymphadenektomie(RPLA) - Nervenerhaltende
Operationstechnik. Foster, R.S., Donohue, J.P., and Albers, P.
Akt. Urol., 24-1X, 1993.
High Intensity Focused Ultrasound in the Treatment of Prostatic
Tissue.
Bihrle, R., Foster, R.S., Sanghvi, N.T., Fry, F.J. and
Donohue, J.P. Urology, Suppl. Vol. 43, No. 2, February, 1994.
The Correlation of P53 Protein Expression with Proliferative
Activity and Occult Metastases in Clinical Stage I Non-seminomatous
Germ Cell Tumors of the Testis. Ulbright, T.M., Orazi, A., deRiese,
W., deRiese, C., Messemer, J.E., Foster, R.S., Donohue, J.P., and
Eble, J.N. Modern Pathology, Vol. 7, No. 1, p. 64, 1994.
Splenic Rupture During Occlusion of the Porta Hepatis in Resection of
Tumors with Vena Caval Extension.
Baniel, J., Bihrle, R., Wahle,
G.R., and Foster, R.S. Journal of Urology, Vol. 151:992-994, 1994.
High Intensity Focused Ultrasound for the Treatment of Benign
Prostatic Hyperplasia:
Early United States Clinical Experience.
Bihrle, R., Foster, R.S., Sanghvi, N.T., Donohue, J.P., and Hood,
P.J. Journal of Urology,Vol. 151:1271-1275, May, 1994.
Chyloperitoneum
Following
Treatment
for
Advanced
Gynecologic
Malignancies.
Geisler, J.P., Foster, R.S., and Sutton, G.P.
Obstetrics & Gynecology, Vol. 83, No. 5, Part 2, May, 1994.
Neovascularization in Clinical Stage A Testicular Germ Cell Tumor:
Prediction of Metastatic Disease.
Olivarez, D., Ulbright, T.,
DeRiese, W., Foster, R., Reister, M.S., Einhorn, L., and Sledge, G.
Cancer Research, Vol. 54, No. 10, pp. 2800-2802, May, 1994.
Quantitative DNA Measurement by Flow Cytometry and Image Analysis of
Human Nonseminomatous Germ Cell Testicular Tumors.
deRiese, W.,
Walker, E.B., deRiese, C., Ulbright, T.M., Crabtree, W.N., Messemer,
J., Jones, J.A., Hinkel, A., Foster, R.S., Donohue, J.P., and Senge,
T. Urol. Res. 22:213-220, May, 1994.
7
Transrectal High Intensity Focused Ultrasound for Treatment of BPH.
Hood, P.J., Bihrle, R., Foster, R.S., and Sanghvi, N.T. Journal of
Urological Nursing, Vol. 13, No. 2, June, 1994.
Flow Cytometric and Quantitative Histologic Parameters as Prognostic
Indicators for Occult Retroperitoneal Disease in Clinical Stage I
Nonseminomatous Testicular Germ Cell Tumors.
DeRiese, T.W.,
DeRiese, C., Ulbright, T.M., Walker, E.B., Messemer, J., Jones,
J.A., Reister, T., Albers, P., Allhoff, E.P., Foster, R.S., and
Donohue, J.P. Int. J. Cancer 57:628-633, 1994.
Benefits of Post Chemotherapy Surgery for Testicular Cancer. Little,
J.S., Foster, R.S., and Donohue, J.P. Contemporary Urology, Vol. 6,
No. 6, pp. 50-63, 1994.
Stage I Nonseminomatous Germ Cell Testicular Cancer - Management
Options and Risk-Benefit Considerations. Donohue, J.P., Thornhill,
R.S., Foster, R.S., Rowland, R.G., and Bihrle, R. World J. of Urol.
612:1-7, 1994.
Complications of Primary Retroperitoneal Lymph Node Dissection.
Baniel, J., Foster, R.S., Rowland, R.G., Bihrle, R., and Donohue,
J.P. J. Urol. 152:424, 1994.
Nerve-Sparing
Retroperitoneal
Lymphadenectomy
after
Primary
Chemotherapy for Metastatic Testicular Carcinoma.
Wahle, G.R.,
Foster, R.S., Bihrle, R., Rowland, R.G., Bennett, R.M., and Donohue,
J.P. J. Urol. 152:428, 1994.
Fertility of Patients with Clinical Stage I Testis Cancer Managed by
Nerve-Sparing Retroperitoneal Lymph Node Dissection.
Foster, R.S.,
McNulty, A., Rubin, L.R., Bennett, R., Rowland, R.G., Sledge, G.W.,
Bihrle, R., and Donohue, J.P. J. Urol. 152:1139, 1994.
Unusual Neoplasms Detected in Testis Cancer Patients Undergoing Post
Chemotherapy Retroperitoneal Lymphadenectomy. Little, J.S., Foster,
R.S., Ulbright, T.M., and Donohue, J.P. J. Urol. 152:1144, 1994.
Predictive
Parameters
of
Biologic
Behavior
of
Early
Stage
Nonseminomatous Testicular Germ Cell Tumors. deRiese, W.T., Albers,
P., Walker, E.B., Ulbright, T.M., Crabtree, W.N., Reister, T.,
Foster, R.S., and Donohue, J.P. Cancer, Vol. 74, No. 4, pp.
1335-1341, August, 1994.
Vascular Considerations in Post Chemotherapy Retroperitoneal Lymph
Node Dissection: Part I - Vena Cava.
Donohue, J.P., Thornhill,
J.A., Foster, R.S., and Bihrle, R.
World J. Urology 12:182-186,
1994.
Vascular Considerations in Post Chemotherapy Surgery for Testis
Cancer, Part II - Aortic. Donohue, J.P., Foster, R.S., Bihrle, R.,
8
et al:
Symposium on Testis Cancer. Weissbach, L. and Donohue, J.
(eds) Part II - Springer - Verlag, World J. Urol. - Special Edition,
August,1994.
Growing Teratoma Syndrome after Chemotherapy for Germ Cell Tumors of
the Ovary.
Geisler, J.P., Goulet, R., Foster, R.S., and Sutton,
G.P. Obstetrics & Gynecology Vol. 84, No. 4, Part 2, October, 1994.
Complications of Primary Retroperitoneal Lymph Node Dissection for Low
Stage Testicular Cancer.
Baniel, J., Foster, R.S., Rowland, R.G.,
Bihrle, R., and Donohue, J.P. World J. Urol. 12:139, 1994.
Fertility Considerations in Nerve-Sparing Retroperitoneal Lymph Node
Dissection.
Foster, R.S., McNulty, A., Rubin, L.R., Bennett, R.,
Rowland, R.G., Sledge, G.W., Bihrle, R., and Donohue, J.P. World J.
Urol. 12:136, 1994.
Predictive
Parameters
in
Biologic
Assessment
of
Low
Stage
Retroperitoneal Lymph Node Dissection.
Albers, P., deRiese, W.,
Walker, E.B., Ulbright, T.M., Crabtree, W.N., Reister, T., Foster,
R.S., and Donohue, J.P. World J. Urol. 12:120, 1994.
Stage II Nonseminomatous Germ-Cell Testicular Tumors:
The Indiana
Experience and Risk-Benefit Analysis.
Foster, R.S., Bihrle, R.,
Little, J.S., Rowland, R.G., and Donohue, J.P.
World J. Urol.
12:143, 1994.
High Intensity Focused Ultrasound for the Treatment of Benign
Prostatic Hypertrophy.
Foster, R.S., Bihrle, R., Sanghvi, N., and
Donohue, J.P.
Seminars in Oncology Vol. VII, No. 3, pp 200-204,
August, 1994.
High Intensity Focused Ultrasound.
Foster, R.S. and Bihrle,
Current Opinion in Urol. Vol. 5, No. 1, pp 10-12, January, 1995.
R.
The Role of Retroperitoneal Lymphadenectomy in Clinical Stage B Testis
Cancer:
The Indiana University Experience (1965-1989). Donohue,
J.P., Thornhill, J.A., Foster, R.S., Rowland, R.G., and Bihrle, R.
J. Urol. 153:85-89, 1995.
Immunohistochemical Assessment of Tumor Proliferation and Volume of
Embryonal Carcinoma Identify Patients with Clinical Stage A
Nonseminomatous Testicular Germ Cell Tumor at Low Risk for Occult
Metastasis.
Albers, P., Miller, G.A., Orazi, A., Ulbright, T.M.,
Albers, J., Donohue, J.P., and Foster, R.S. Cancer Vol. 75, No. 3,
pp 844-850, 1995.
Complications
of
Post
Chemotherapy
Retroperitoneal
Lymph
Node
Dissection.
Baniel, J., Foster, R.S., Rowland, R.G., Bihrle, R.,
and Donohue, J.P. J. Urol. 153:976-980, March, 1995.
9
Surgical Anatomy of Lumbar Vessels: Implications for Retroperitoneal
Surgery.
Baniel, J., Foster, R.S., and Donohue, J.P.
J. Urol.
153:1422-1425, 1995.
Adult Primary Pure Teratoma of the Testis.
Leibovitch, I., Foster,
R.S., Ulbright, T.M., and Donohue, J.P. Cancer Vol. 75, No. 9, pp
2244-2250, May, 1995.
Late Relapse of Testicular Cancer.
Baniel, J., Foster, R.S., Gonin,
R., Messemer, J.E., Donohue, J.P., and Einhorn, L.H. J. Clin. Oncol.
Vol. 13, No. 5, pp 1170-1176, May, 1995.
Ectopic Ureters and Ureteroceles in Adults. Albers, P., Foster, R.S.,
Bihrle, R., Adams, M.C., and Keating, M.A. Urology Vol. 45, No. 5,
pp 870-874, May, 1995.
Immunhistochemische Bestimmung der Tumorzellproliferation (MIB-1) und
Volumen des Embryonalzellkarzinomanteils. Albers, P., Miller, G.A.,
Orazi, A., Ulbright, M., Albers, J., Foster, R.S., and Donohue, J.P.
Akt. Urol. 26:89-95, 1995.
Color Doppler Flow Imaging for Deep Venous Thrombosis Screening in
Patients Undergoing Pelvic Lymphadenectomy and Radical Retropubic
Prostatectomy for Prostatic Carcinoma.
Leibovitch, I., Foster,
R.S., Wass, J.L., Rowland, R.G., et al.
J. Urol. 153:1866-1869,
1995.
Cost and Risk Benefit in the Management of Clinical Stage II
Nonseminomatous Testicular Tumors. Baniel, J., Roth, B.J., Foster,
R.S., and Donohue, J.P. Cancer Vol. 75, No. 12, June, 1995.
Prognostic Significance of Immunohistochemical Proliferation Markers
(Ki-67/MIB-1 and Proliferation-Associated Nuclear Antigen), p53
Protein Accumulation, and Neovascularization in Clinical Stage A
Nonseminomatous Testicular Germ Cell Tumors. Albers, P., Orazi, A.,
Ulbright, T.M., Miller, G.A., Haidar, J.H., Donohue, J.P., and
Foster, R.S. Mod. Path. Vol. 8, No. 5, pp 492-497, 1995.
The Clinical Implications of Procedural Deviations During Orchiectomy
for Nonseminomatous Testis Cancer. Leibovitch, I., Baniel, J.,
Foster, R.S., and Donohue, J.P. J. Urol. 154:935-939, 1995.
The Management of Patients with Clinical Stage I Nonseminomatous
Testicular Tumors and Persistently Elevated Serologic Markers.
Saxman,S.B., Nichols, C.R., Foster, R.S., et al.
J. Urol,
155:587-589, 1995.
Neue Parameter zur Vorhersage des Pathologischen Stadiums bei
Nicht-Seminomatosen Hodentumoren im Klinischen Stadium I.
Albers,
P., Ulbright, T.M., Albers, J., Miller, G.A., Foster, R.S., and
Donohue, J.P. Urologe A 34:316-323, 1995.
10
Flow Cytometric and Cytophotometric DNA Analysis Cannot Predict
Subsequent Tumour Recurrence in Pathological Stage B1 and B2
Nonseminomatous Testicular Germ Cell Tumour Patients who do not
Receive Adjuvant Chemotherapy.
Albers, P., Miller, G.A., Albers,
J.,Cummings, O.W., Boris, M., Ulbright, T.M., Donohue, J.P., and
Foster, R.S. Eur. J. Cancer 31A:848, 1995.
Prognostic
Factors
in
Patients
with
Pathological
Stage
A
Nonseminomatous Testicular Germ Cell Tumours and Tumour Recurrence
during Follow-up. Albers, P., deRiese, W., Ulbright, T.M., Walker,
E.B., and Foster, R.S. Urol. Res. 23:211-213, 1995.
Prognostische Bedeutung der Expression von Ki-67/MIB-1,p53, PCNA und
F-VIII-RA
im
Klinischen
Stadium
I
des
Nicht-Seminomatosen
Hodentumors.
Albers, P., Orazi, A., Ulbright, T.M., Foster, R.S.,
and Donohue, J.P. Akt. Urol. 26:38-41, 1995.
Early Urethral Catheter Removal Following Radical Prostatectomy: A
Pilot Study. Little, J.S., Bihrle, R., and Foster, R.S. Urology 46
(3), pp 429-431, September, 1995.
Late Relapse of Clinical Stage I Testicular Cancer.
Foster, R.S., Einhorn, L.H., and Donohue, J.P.
154:1370-1372, 1995.
Baniel, J.,
J. Urol.
Clinical Stage B Nonseminomatous Germ Cell Testis Cancer: The Indiana
University
Experience
(1965-1989)
Using
Routine
Primary
Retroperitoneal Lymph Node Dissection.
Donohue, J.P., Thornhill,
J.A., Foster, R.S., et al.
Eur. J. Of Cancer, Vol. 31A, #10, pp
1599-1604, October, 1995.
Hyperamylasemia After Post Chemotherapy Retroperitoneal Lymph Node
Dissection for Testis Cancer.
Baniel, J., Leibovitch, I., Foster,
R.S., et al. J. Urol., 154:1373-1375, October, 1995.
Cystography
after
Radical
Retropubic
Prostatectomy:
Clinical
Implications of Abnormal Findings.
Leibovitch, I., Rowland, R.G.,
Little, J.S., Foster, R.S., Bihrle, R., and Donohue, J.P.
Urol.
46:78-80, 1995.
Improved Accuracy of Computerized Tomography Based Clinical Staging in
Low Stage Nonseminomatous Germ Cell Cancer Using Size Criteria of
Retroperitoneal Lymph Nodes. Leibovitch, I., Foster, R.S., Kopecky,
K.K., and Donohue, J.P. J. Urol. 154:1759-1763, November, 1995.
Defining New Standards for Adjuvant Therapy of Testis Cancer. (An
Editorial)
Nichols, C.R., Gonin, R., and Foster, R.S. J. Clin.
Oncol., Vol. 13, No. 11, November, 1995.
Ultrasound
and
Microbubbles:
Their
Generation,
Detection,
and
11
Potential Utilization in Tissue and Organ Therapy--Experimental.
Fry, F.J., Sanghvi, N.T., Foster, R.S., Bihrle, R., and Hennige, C.
Ultrasound in Med. & Biol., Vol. 21, No. 9, pp. 1227-1237, 1995.
Identification of Multiple Chromosome 12 Abnormalities in Human
Testicular Germ Cell Tumors by Two-Color Fluorescence In Situ
Hybridization (FISH).
Smolarek, T.A., Blough, R.I., Foster, R.S.,
Ulbright, T.M., Palmer, C.G., and Heerema, N.A. Genes, Chromosomes &
Cancer, 14:252-258, 1995.
Cost and Risk-Benefit Considerations in the Management of Clinical
Stage I Nonseminomatous Testicular Tumors. Baniel, J., Roth, B.J.,
Foster, R.S., and Donohue, J.P. Ann. Surg. Onc., Vol. 3, No. 1, pp.
86-93, 1996.
Tumor Proliferative Activity is Predictive of Pathological Stage in
Clinical Stage A Nonseminomatous Testicular Germ Cell Tumors.
Albers, P., Ulbright, T.M., Albers, J., Miller, G.A., Orazi, A.,
Crabtree, W.N., Baniel, J., Reister, T., Sidner, R.A., Foster, R.S.,
and Donohue, J.P. J. Urol. 155:579-586, 1996.
Delayed Orchiectomy After Chemotherapy for Metastatic Nonseminomatous
Germ Cell Tumors.
Leibovitch, I., Little, J.S., Foster, R.S.,
Rowland, R.G., Bihrle, R., and Donohue, J.P. J. Urol. 155:952-954,
1996.
The Impact of Pre-Donated Autologous Blood and Intraoperative
Isovolaemic Haemodilution on the Outcome of Transfusion in Patients
Undergoing
Radical
Retropubic
Prostatectomy.
Nash,
P.A.,
Schrepferman, C.G., Rowland, R.G., Young, J., Foster, R.S., Bihrle,
R., and Donohue, J.P. Brit. J. Urol. 77:856-860, 1996.
Spinal Cord Ischemia After Post Chemotherapy Retroperitoneal Lymph
Node Dissection for Nonseminomatous Germ Cell Cancer. Leibovitch,
I., Nash, P.A., Little, J.S., Foster, R.S., and Donohue, J.P.
J.
Urol. 155:947-951, 1996.
Testis Cancer:
What is the Appropriate Follow up After Treatment?
Sharir, S., Foster, R.S., Donohue, J.P., and Jewett, M.A.S. Sem. In
Urol. Oncol. 14:45-53, 1996.
Teratoma in the Orchiectomy Specimen and Volume of Metastasis are
Predictors of Retroperitoneal Teratoma in Low Stage Nonseminomatous
Testis Cancer.
Foster, R.S., Baniel, J., Leibovitch, I., Curran,
M., Bihrle, R., et al. J. Urol. 155:1943-1945, 1996.
Biology of Metastases and its Clinical Implications: Testicular Germ
Cell Tumors.
Donohue J.P., Foster, R.S., Little, J.S., Loehrer,
P.J., and Einhorn, L.H. World J. Urol. 14:197-203, 1996.
Noninvasive
Ultrasonic
Subtotal
Ablation
of
the
Prostate
in
Dogs.
12
Kincaide, L.F., Sanghvi, N.T., Cummings, O., Bihrle, R., Foster,
R.S., et al. AJVR 57:1225-1227, 1996.
Nerve Sparing Post Chemotherapy Retroperitoneal Lymph Node Dissection
for Advanced Testicular Cancer.
C.L. Coogan, M.J. Hejase, G.R.
Wahle, R.S. Foster, etal. J. Urol. 156:1656-1658, 1996.
Noninvasive Surgery of Prostate Tissue by High Intensity Focused
Ultrasound.
Sanghvi, N.T., Fry, F.J., Bihrle, R., Foster, R.S.,
Phillips, M.H., et al.
IEEE Transactions on Ultrasonics,
Ferroelectrics, and Frequency Control. Vol. 43, No. 6, pp 1099-1110,
November, 1996.
Urethral Catheter Removal Prior to Hospital Discharge Following
Radical Prostatectomy. Coogan, C.L., Little, J.S., Bihrle, R., and
Foster, R.S. Urology 49:400-403, 1997.
Primitive Neuroectodermal Tumors Arising in Testicular Germ Cell
Neoplasms. Michael, H., Hull, M.T., Ulbright, T.M., Foster, R.S.,
and Miller, K.D. American Journal of Surgical Pathology 21 (8):896904, 1997.
Post Chemotherapy Retroperitoneal Lymph Node Dissection is Effective
Therapy in Selected Patients with Elevated Tumor Markers after
Primary Chemotherapy Alone.
Coogan, C.L., Foster, R.S., Rowland,
R.G., Bihrle, R., et al. Urology 50(6):957-962, 1997.
Fluorescence In Situ Hybridization on Nuclei from Paraffin-Embedded
Tissue in Low Stage Pure Embryonal Carcinoma of the Testis. Blough,
R.I., Heerema, N.A., Albers, P., and Foster, R.S. Journal of Urology
159:240-244, 1998.
Identification of Clinical Stage A Nonseminomatous Testis Cancer
Patients at Extremely Low Risk for Metastatic Disease: A Combined
Approach Using Quantitive Immunohistochemical, Histopathologic, And
Radiologic Assessment. Leibovitch, I., Foster, R.S., Kopecky, K.K.,
Albers, P., et al.
Journal of Clinical Oncology 16 (1):261-268,
1998.
En
Bloc
Nephrectomy
in
Patients
Undergoing
Post
Chemotherapy
Retroperitoneal Lymph Node Dissection for Nonseminomatous Testis
Cancer: Indications, Implications and Outcomes.
Nash, P.A.,
Leibovitch, I., Foster, R.S., Bihrle, R., et al. Journal of Urology
159:707-710, 1998.
Nephroblastoma Like Tumors in Patients with Testicular Germ Cell
Tumors.
Michael, H., Hull, M.T., Foster, R.S., Sweeney, C.J., and
Ulbright, T.M. The Amer. J. Of Surg. Path. 22(9):1107-1114, 1998.
Clinical Stage I Nonseminoma: Surgery Versus Surveillance. Foster,
R.S. and Roth, B.J. Seminars in Oncology 25:145-153, April, 1998.
13
Integration of Surgery and Systemic Therapy: Results and Principles Of
Integration.
Donohue, J.P., Leibovitch, I., Foster, R.S., Baniel,
J., and Tognoni, P.
Seminars in Urologic Oncology, 16 (2):65-71,
1998.
Bilateral Testicular Tumors: Management and Outcome in 21 Patients.
Coogan, C.L., Foster, R.S., Simmons, G.R., Tognoni, P.G., Roth,
B.J., and Donohue, J.P. Cancer 83:547-552, August, 1998.
Percutaneous Transvesical Drainage of a Seminal Vesicle Abscess.
Smith, Jr., E.R., Trerotola, S.O., and Foster, R.S.
Journal of
Vascular & Interventional Radiology, 9:743-745, 1998.
Cytogenetic Analyses of 85 Testicular Germ Cell Tumors: Comparison Of
Post Chemotherapy and Untreated Tumors.
Smolarek, T.A., Blough,
R.I., Foster, R.S., Ulbright, T.M., Palmer, C.G., and Heerema, N.A.
Cancer Genet Cytogenet, 108:57-69, 1999.
Treatment Options for Stage I Testicular Cancer.
Foster, R.S. and
Donohue, J.P. Contemporary Urology, Vol. 11, #2, 36-41, 1999.
A
Phase II Study of Paclitaxel and Ifosfamide for Patients with
Advanced Refractory Carcinoma of the Urothelium.
Sweeney, C.J.,
Williams, S.D., Finch, D.E., Bihrle, R., Foster, R.S., Collins, M.,
Fox, S., and Roth, B.J. Cancer 86(3):514-518, 1999.
Noninvasive Surgery of Prostate Tissue by High Intensity Focused
Ultrasound: An Updated Report. Sanghvi, N.T., Foster, R.S., Bihrle,
R., Casey, R., Uchida, T., Phillips, M.H., Syrus, J., Zaitsev, A.V.,
Marich, K.W., Fry, F.J. Euro J of Ultrasound 9(1):19-29, 1999.
Secondary Tumors
Testis Cancer.
445, 1999.
After Initial Successful Treatment of Metastatic
Foster, R.S.
Current Opinion in Urology 9(5):443-
Postchemotherapy.
Radical Retroperitoneal Lymph Node Dissection.
Foster, R.S., Bell, B., Donohue, J.P. Atlas of the Urologic
Clinics of North America 7(2):51-63, 1999.
Testicular Cancer: What’s New in Staging, Prognosis, and Therapy.
Foster, R.S., Nichols, C.R. Oncology 13(12):1689-1694, 1999.
Expression of Cyclooxygenase-2 (COX-2) in Human Invasive Transitional
Cell Carcinoma (TCC) of the Urinary Bladder. Mohammed, S.I., Knapp,
D.W., Bostwick, D.G., Foster, R.S., Khan, K.N.M., Masferrer, J.L.,
Woerner, B.M., Snyder, P.W., Koki, A.T.
Cancer Research 59:56475650, 1999.
Hepatic Resection of Metastatic Testicular Carcinoma: A Further
Update.
Hahn, T.L., Jacobson, L., Einhorn, L.H., Foster, R.,
14
Goulet, Jr., R.J. Annals of Surgical Oncology 6(7):640-644, 1999.
The Pathology of Late Recurrence of Testicular Germ Cell Tumors.
Michael, H., Lucia, J., Foster, R.S., Ulbright, T.M.
Am J Surg
Pathol 24:257-273, 2000.
Early Catheter Removal Following Radical Retropubic Prostatectomy.
DeMarco, R.T., Bihrle, R., Foster, R.S.
Seminars in Urol Onc
18(1):57-59, 2000.
Adjuvant Bleomycin, Etoposide and Cisplatin in Pathological Stage II
Non-seminomatous
Testicular
Cancer:
the
Indiana
University
Experience.
Behnia, M., Foster, R., Einhorn, L.H., Donohue, J.,
Nichols, C.R. European J of Cancer 36:472-475, 2000.
A Benign Para-aortic Lymph Node of Histologically Proved Follicular
Hyperplasia Mimicking Metastatic Germ Cell Cancer.
Beck, S.D.W.,
Ulbright, T.M., Foster, R.S. The J. of Urol. 163:1520-1521, 2000.
Testicular Cancer: Increasing in Incidence -and Curability.
Foster,
R., Nichols, C., Sheinfeld, J. Patient Care 34(10):18-37, 2000.
Retroperitoneal Lymph Node Dissection for the Management of Clinical
Stage I Nonseminoma.
Foster, R.S. and Donohue, J.P.
J. of Urol.
163:1788-1792, 2000.
Risk of Systemic Metastases in Clinical Stage I Nonseminoma Germ Cell
Testis Tumor Managed by Retroperitoneal Lymph Node Dissection.
Hermans, B.P.,, Sweeney, C.J., Foster, R.S., Einhorn, L.E., and
Donohue, J.P. J. of Urol. 163:1721-1724, 2000.
Clinical Stage I Pure Yolk Sac Tumor of the Testis in Adults has
Different Clinical Behavior than Juvenile Yolk Sac Tumor.
Foster,
R.S., Hermans, B., Bihrle, R., and Donohue, J.P. J. of Urol.
164:1943-1944, Dec., 2000.
Validation of a Prediction Model and It’s Predictors for the Histology
of Residual Masses in Nonseminomatous Testicular Cancer. Vergouwe,
Y., Steyerberg, E.W., Foster, R.S., Habbema, J.D.F., Donohue, J.P.
J. of Urol. 165:84-88, Jan. 2001.
Altered
Expression
of
Ape
1/ref-1
in
Germ
Cell
Tumors
and
Overexpression in NT2 Cells Confers Resistance to Bleomycin and
Radiation1.
Robertson, K.A., Bullock, H.A., Tritt, Y.X.R.,
Zimmerman, E., Ulbright, T.M., Foster, R.S., Einhorn, L.H., Kelley,
M.R. Cancer Research 01:2220-2225, March, 2001.
Elevated and Altered Expression of the Multifunctional DNA Base
Excision Repair and Redox Enzyme Ape1/ref-1 in Prostate Cancer.
Kelley, M.R., Cheng, L., Foster, R., Tritt, R., Jiang, J.,
Broshears, J., and Koch, M.
Clinical Cancer Research 7:824-830,
15
2001.
Germ Cell Tumor Associated Primitive Neuroectodermal Tumors. Ganjoo,
K.N., Foster, R.S., Michael, H., Donohue, J.P., Einhorn, L.H. J. of
Urol. 165:1514-1515, May, 2001.
Aortic Replacement During Post-Chemotherapy Retroperitoneal Lymph Node
Dissection.
Beck, S.D.W., Foster, R.S., Bihrle, R., Koch, M.O.,
Wahle, G.R., Donohue, J.P. J. of Urol. 165:1517-1520, May, 2001.
The Benefits of Nerve-sparing RPLND in Testicular Cancer.
Foster,
R.S., Bihrle, R., Donohue, J.P.
Contemporary Urol. 13(8):64-76,
Aug., 2001.
Early-stage Testis Cancer. Foster, R.S.
Oncology 2(5):413-419, Oct., 2001.
Current Treatment Options in
Accuracy of Predicting Long-Term Prostate Specific Antigen Outcome
Based on Early Prostate Specific Antigen Recurrence Results After
Radical Prostatectomy. Soergel, T.M., Koch, M.O., Foster, R.S.,
Birhle, R., Wahle, G., Gardner, T., and Jung, S. J. of Urol..
166(6):2198-2201, Dec., 2001.
Percutaneous Imaging-Guided Access for the Treatment of Calculi in
Continent Urinary Reservoirs. Davis, W.B., Trerotola, S.O.,
Johnson, M.S., Patel, N.H., Namyslowski, J., Stecker, M.S.,
McLennan, G., Shah, H., Bihrle, R., Foster, R. Cardiovasc and
Intervent Radiol 25:119-1222, 2002.
Teratoma in the Orchiectomy Specimen and Volume of Metastasis are
Predictors of Retroperitoneal Teratoma in Post-Chemotherapy
Nonseminomatous Testis Cancer. Beck, S.D.W., Foster, R.S., Bihrle,
R., Ulbright, T., Koch, M.O., Wahle, G.R., Einhorn, L.H., and
Donohue, J.P. J. of Urol. 168:1402-1404, October, 2002.
Current Status of Retroperitoneal Lymph Node Dissection and Testicular
Cancer: When to Operate. Foster, R. and Bihrle, R. Cancer Control
9(4):277-283, 2002.
Update on Late Relapse of Germ Cell Tumor: A Clinical and Molecular
Analysis. George, D.W., Foster, R.S., Hromas, R.A., Robertson,
K.A., Vance, G.H., Ulbright, T.M., Gobbett, T.A., Heiber, D.J.,
Heerema, N.A., Ramsey, H.C., Thurston, V.C., Jung, S., Shen, J.,
Finch, D.E., Kelley, M.R., Einhorn, L.H. J. of Clin. Onc.
21(1):113-122, 2003.
Anatomic Distribution of Periprostatic Adipose Tissue. A Mapping Study
of 100 Radical Prostatectomy Specimens. Hong, H., Koch, M.O.,
Foster, R.S., Bihrle, R., Gardner, T.A., Fyffe, J., Ulbright, T.M.,
Eble, J.N., Cheng, L. Cancer 97(7):1-6, 2003.
16
Molecular Evidence Supporting the Neoplastic Nature of Some Epidermoid
Cysts in the Testis. Younger, C., Ulbright, T.M., Zhang, S.,
Billings, S.D., Cummings, O.W., Foster, R.S., Eble, J.N., and Chen,
L. Arch Pathol Lab Med 127(7):858-860, July, 2003.
Is Post-chemotherapy Resection of Seminomatous Elements Associated
with Higher Acute Morbidity? Mosharafa, A.A., Foster, R.S.,
Leibovich, B.C., Bihrle, R., Johnson, C., and Donohue, J.P. J. of
Urol. 169:2126-2128, June, 2003.
Biochemical disease-free survival in patients with a high prostatespecific antigen level (20-100 ng/mL) and clinically localized
prostate cancer after radical prostatectomy. Brandli, D.W., Koch,
M.O., Foster, R.S., Bihrle, R., and Gardner, T.A. BJU International
92(1):19-23, July 2003.
Does Retroperitoneal Lymph Node Dissection Have a Curative Role for
Patients with Sex Cord-Stromal Testicular Tumors? Mosharafa, A.A.,
Foster, R.S., Bihrle, R., Koch, M.O., Ulbright, T.M., Einhorn, L.H.,
Donohue, J. Cancer 098(04):753-757, August 2003.
Stroma Adjacent to Metastatic Mature Teratoma after Chemotherapy for
Testicular Germ Cell Tumors Is Derived from the Same Progenitor
Cells as the Teratoma. Brandli, D.W., Ulbright, T.M., Foster, R.S.,
Cummings, O.W., Zhang, S., Sweeney, C.J., Eble, J.N., and Cheng, L.
Cancer Research 63:1-6, September 2003.
Molecular Evidence Supporting the Neoplastic Nature of Some Epidermoid
Cysts of the Testis. Younger, C., Ulbright, T.M., Zhang, S.,
Billings, S.D., Cummings, O.W., Foster, R.S., Eble, J.N., Cheng, L.
Archives of Pathology and Laboratory Medicine 127(7):858-860, 2003.
Identical Allelic Losses in Mature Teratoma and Other Histologic
Components of Malignant Mixed Germ Cell Tumors of the Testis.
Kernek, K.M., Ulbright, T.M., Zhang, S., Billings, S.D., Cummings,
O.W., Henley, J.D., Michael, H., Brunelli, M., Martignoni, G.,
Foster, R.S., Eble, J.N., and Cheng, L. Amer J of Path 163(6): ,
December 2003.
Histology in Mixed Germ Cell Tumors. Is There a Favorite Pairing?
Mosharafa, A.A., Foster, R.S., Leibovich, B.C., Ulbright, T.M.,
Bihrle, R., Einhorn, L.H., Donohue, J.P. J of Urol 171:1471-1473,
April 2004.
Complications of Post-chemotherapy Retroperitoneal Lymph Node
Dissection for Testis Cancer. Mosharafa, A.A., Foster, R.S., Koch,
M.O., Bihrle, R., and Donohue, J.P. J of Urol 171:1839-1841, May
2004.
Nephroblastoma Arising in a Germ Cell Tumor of Testicular Origin.
Emerson, R.E., Ulbright, T.M., Zhang, S., Foster, R.S., Eble, J.N.
17
and Cheng, L.
Am/Surg Pathol 28(5):687-692, May 2004.
Secondary surgery in germ cell tumors - when and how extensively
should it be performed? Foster, R.S., Beck, S., Bihrle, R. World J
Urol 22:37-40, 2004.
Gene Expression Profiling of Early- and Late-Relapse Nonseminomatous
Germ Cell Tumor and Primitive Neuroectodermal Tumor of the Testis.
Sugimura, J., Foster, R.S., Cummings, O.W., Kort, EJ., Takahashi,
M., Lavery, T.T., Furge, K.A., Einhorn, L.H., and Bin Tean The.
Clinical Cancer Research 10:2368-2378, 2004.
Surgical Atlas. Modified Retroperitoneal Lymphadenectomy.
R.S., BJU International 94(6):941-955, 2004.
Foster,
Cystic Trophoblastic Tumor. A Nonaggressive Lesion in Postchemotherapy
Resections of Patients With Testicular Germ Cell Tumors. Ulbright,
T.M., Henley, J.D., Cummings, O.W. Foster, R.S., Cheng, L. Am Surg
Pathol 28(9):1212-1216, 2004.
The Combined Percentage of Gleason Patterns 4 and 5 Is the Best
Predictor of Cancer Progression After Radical Prostatectomy. Cheng,
L., Koch, M.O., Juliar, B.E., Daggy, J.K., Foster, R.S., Bihrle, R.,
Gardner, T. A. J of Clin Onc 23(13), May, 2005.
Impact of the Number of Positive Lymph Nodes on Disease-free Survival
in Patients with Pathological Stage B1 Nonseminomatous Germ Cell
Tumor. Beck, S.D.W., Foster, R.S., Bihrle, R., Cheng, L., Ulbright,
T.M., and Donohue, J.P. J. of Urol. 174:143-145, 2005.
Outcome Analysis for Patients With Elevated Serum Tumor Markers at
Postchemotherapy Retroperitoneal Lymph Node Dissection. Beck,
S.D.W., Foster, R.S., Bihrle, R., Einhorn, L.H., Donohue, J.P. J of
Clin Onc 23(25):6149-6156, September 1, 2005.
Does the Histology of Nodal Metastasis Predict Systemic
Retroperitoneal Lymph Node Dissection in Pathological
Cell Tumors? Beck, S.D.W., Foster, R.S., Bihrle, R.,
Donohue, J.P. J. of Urol. 174(4):1287-1290, October,
Relapse After
Stage B1 Germ
Cheng, L.,
2005.
Pathologic Findings and Therapeutic Outcome of Desperation Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Germ
Cell Cancer. Beck, S.D.W., Foster, R.S., Bihrle, R., Einhorn, L.H.,
Donohue, J.P. Urologic Oncology: Seminars and Original
Investigations 23:423-430, 2005.
Point and Counterpoint. Treating Stage 1 Testis Cancer. Should
laparoscopic RPLND replace open RPLND as the standard of care?
Orvieto, Marcelo, Shalhav, Arieh L., and Foster, Richard S.
Contemporary Urology, 18(5):29-38, 2006.
18
Interphase fluorescence in situ hybridization analysis of chromosome
12p abnormalities is useful for distinguishing epidermoid cyst of
the testis from pure mature teratoma. Cheng, L., Zhang, S.,
MacLennan, G.T., Poulos, C.K., Sung, M.T., Beck, S.D., Foster, R.S.
Clin Cancer Res 12:5668-5772, 2006.
Long-term outcome of retroperitoneal lymph node dissection in the
management of testis cancer. Beck, S.D.W. and Foster, R.S. World J
of Urol 24:267-272, 2006.
Clonal Origin of Metastatic Testicular Teratomas. Jones, T.D., Wang,
M., Sung, M., Zhang, S., Ulbright, T.M., Eble, J.N., Beck, S.D.,
Foster, R.S., Anagnostou, Jr., J.J., Conner, C., Cheng, L. Clin
Cancer Res 12(18):5377-5383, 2006.
The Moore/Daneshmand/Kondagunta/Nichols Article Reviewed. (Management
of Difficult Germ-Cell Tumors. Moore, C.J., Daneshmand, S.,
Kondagunta, G.V.,Nichols, C.R.)Oncology 20(12):1576-1578, 2006.
Predicting Retroperitoneal Histology in Postchemotherapy Testicular
Germ Cell Cancer: A Model Update and Multicentre Validation with
More Than 1000 Patients. Vergouwe, Y., Steyerberg,E.W., Foster,
R.S., Sleifer, D.T., Fossa, S.D., Gerl, A., de Wit, R., Roberts,
J.T., Habbema, J.D.F. European Urology 51:424-432, 2006.
In primo piano: Il Cancro Del Testicolo.
Urologicia e Salute 6:1-8, 2006
D’Elia, G. and Foster, R.S.
Significance of Primary Tumor Size and Preorchiectomy Serum Tumor
Marker Level in Predicting Pathologic Stage at Retroperitoneal Lymph
Node Dissection in Clinical Stage A Nonseminomatous Germ Cell
Tumors. Beck, S.D.W., Foster, R.S., Bihrle, R., Donohue, J.P.
Urology 69(3):557-559, 2007.
Does the Presence of Extranodal Extension in Pathological Stage B1
Nonseminomatous Germ Cell Tumor Necessitate Adjuvant Chemotherapy?
Beck, S.D.W., Cheng, L., Bihrle, R., Donohue, J.P. and Foster, R.S.
J of Urol 177:944-946, March 2007.
Molecular genetic evidence supporting the neoplastic nature of stromal
cells in ‘fibrosis’ after chemotherapy for testicular germ cell
tumours. Cheng, L., Zhang, S., Wang, M. Davidson, D.D., Morton,
M.J., Huang, J. Zheng, S., Jones, T.D., Beck, S.D., Foster, R.S. J
Pathol 213:65-71, 2007.
Short-Term Morbidity of Primary Retroperitoneal Lymph Node Dissection
in a Contemporary Group of Patients. Beck, S.D.W., Peterson, M.D.,
Bihrle, R., Donohue, J.P., Foster, R.S. J of Urol 178:504-506,
2007.
The Role of Surgery in the Management of Recurrent or Persistent Non-
19
seminomatous Germ Cell Tumors.
Update Series 5 163-176, 2007.
Jacobsen, N, Foster, R.S.
EAU-EBU
Is Full Bilateral Retroperitoneal Lymph Node Dissection Always
Necessary for Postchemotherapy Residual Tumor? Beck, S.D.W.,
Foster, R.S., Bihrle, R., Donohue, J.P., Einhorn, L.H. Cancer
110(6):1235-1240, 2007.
Epidermal growth factor receptor protein expression and gene
amplification in the chemorefractory metastatic embryonal carcinoma.
Zhang, S., Maclennan, G.T., Biermann, K., Foster, R.S., Beck,
S.D.W., Cheng, L. Mod Pathol 22:7-12, 2009.
Use of Ileum as Ureteral Replacement in Urological Reconstruction.
Armatys, S.A., Mellon, M.J., Beck, S.D.W., Koch, M.O., Foster, R.S.,
Bihrle, R. J. of Urol. 181:1-6, Jan 2009.
Long-Term Outcome for Patients With High Volume Retroperitoneal
Teratoma Undergoing Post-Chemotherapy Surgery. Beck, S.D.W.,
Foster, R.S., Bihrle, R., Einhorn, L.H., and Donohue, J.P. J. of
Urol. 181(6):2526-2532, June 2009.
Management of the post chemotherapy subcentimeter residual mass: the
case for observation. Beck, S.D.W. and Foster, R.S. World J. of
Urol. 27(4):485-488, August 2009.
Results of
patients
elevated
Einhorn,
retroperitoneal lymph node dissection after chemotherapy in
with pure seminoma in the orchidectomy specimen but
serum α-fetoprotein. Peterson, M., Beck, S., Bihrle, R.,
L., and Foster, R. BJUI 104:176-178, 2009.
Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients
With Disseminated Nonseminomatous Germ Cell Tumors: Is a
Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After
Complete Remission? Ehrlich, Y., Brames, M.J., Beck, S.D.W., Foster,
R.S., Einhorn, L.H. J. of Clin. Onc. 28(4):531-536, 2010.
Outcome Analysis of Patients with Transformed Teratoma to Primitive
Neuroectodermal Tumor. Ehrlich, Y., Beck, S.D.W., Ulbright, T.M.,
Cheng, L., Brames, M.J., Andreoiu, M., Foster, R.S., Einhorn, L.H.
Ann Onc 10:1093, 2010.
POSTGRADUATE COURSES
Nerve-Sparing Techniques in Urologic Surgery.
Donohue, JP.,
20
Andriole, Jr., GL., Brendler, CB., and Foster, RS.
American Urological Association, 1991, Toronto, CN.
Nerve-Sparing Techniques in Urologic Surgery. Donohue, JP.,
Andriole, Jr., GL., Brendler, CB., and Foster, RS.
American Urological Associaton, 1992, Washington, D.C.
Nerve-Sparing Techniques in Urologic Surgery. Donohue, JP.,
Andriole, Jr., GL., Brendler, CB., and Foster, RS.
American Urological Association, 1993, San Antonio, TX.
Nerve-Sparing Techniques in Urologic Surgery. Donohue, JP.,
Andriole, Jr., GL., Brendler, CB., and Foster, RS.
American Urological Association, 1994, San Francisco, CA.
Nerve-Sparing Techniques in Urologic Surgery. Donohue, JP,
Andriole, Jr., GL, Foster, RS, and Brendler, CB.
American Urological Association, 1995, Las Vegas, NV.
Nerve-Sparing Techniques in Urologic Surgery. Donohue, JP,
Andriole, Jr., GL, Foster, RS, and Steinberg, GD.
American Urological Association, 1996, Orlando, FL.
LECTURES
Invited Speaker - Current Diagnosis and Treatment of Prostate
Cancer, April 21, 1988, St. Joseph's Hospital, Huntingburg,
Indiana.
Invited Speaker - Nerve-Sparing Retroperitoneal Lymph Node
Dissection, April 22, 1988, Lincoln Hotel, Indianapolis, Indiana.
Invited Speaker - Current Diagnosis and Management of Urinary
Tract Infection, April 13, 1988, St. Mary's Hospital, Evansville,
Indiana.
Invited Speaker - Urinary Tract Infections, October 2, 1988,
Parkview Memorial Hospital, Fort Wayne, Indiana.
Invited Speaker - Continent Urinary Diversion after Radical
Cystectomy, October 15, 1988, Camden-Clark Memorial Hospital,
Parkersburg, West Virginia.
Invited Speaker - Renal Cancer: Diagnosis and Management,
April 15, 1989, Indiana University Surgery Department,
Grand Rounds.
Invited Speaker - Prostatic Carcinoma, August 5, 1989, Indiana
21
Academy of Family Physicians, French Lick Springs Resort,
French Lick, Indiana.
Invited Speaker - What's New in Urologic Cancer, Indiana
Urologic Nursing Assn., October 5, 1989, Indianapolis, Indiana.
Invited Speaker - Prostatic Specific Antigen: Use and Misuse,
Hoosier Oncology Group, October 7, 1989, Indianapolis, Indiana.
Invited Speaker - Advances in the Diagnosis and Management
of Prostate Malignancy, October 24, 1989, Deaconess Hospital,
Evansville, Indiana.
Invited Speaker - Current Treatment of Testicular Cancer,
December 2, 1989, I.U. Surgical Department, Grand Rounds,
Indianapolis, Indiana.
Invited Speaker - Voiding Abnormalities in Multiple Sclerosis
Patients, December 9, 1989, Indiana Chapter MS Society
Seminar, Indianapolis, Indiana.
Invited Speaker - Prostate Cancer, February 8, 1990, Dept. of
Family Medicine, I.U. Medical Center, Indianapolis, Indiana.
Invited Speaker - Continent Urinary Diversion, February 27,
1990, Dayton Surgical Society, Dayton, Ohio.
Invited Speaker - Nerve-Sparing Retroperitoneal Lymph Node
Dissection for Testis Cancer, February 28, 1990, St. Elizabeth
Medical Center, Surgical Grand Rounds, Dayton, Ohio.
Invited Speaker - Prostate Cancer, February 2, 1991, I.U.
Surgical Dept., Grand Rounds, Indianapolis, Indiana.
Invited Speaker - Carcinoma of the Prostate/Radical Prostatectomy, April 24, 1991, Operating Room Nursing Staff, I.U.
and Riley Hospitals, Indianapolis, Indiana.
Invited Speaker - Prostate Cancer, May 8, 1991, St. John's
Hospital, Continuing Medical Education Meeting, Anderson,
Indiana.
Invited Speaker - Nerve-Sparing Retroperitoneal Lymph Node
Dissection, June 27, 1991, Mexican Urologic Society,
Guadalajara, Mexico.
Invited Speaker - Chemotherapy of Testis Carcinoma, June 27,
1991, Mexican Urologic Society, Guadalajara, Mexico.
Invited Speaker - Diagnosis and Advances in the Treatment of
Prostate Cancer, October 8, 1991, An Evening of Practical
22
Urology Meeting, Reid Memorial Hospital, Richmond, Indiana.
Invited Speaker - Focused Ultrasound, New Techniques in
Prostatic Outflow Obstruction, March 18, 1992, Institute of
Urology & Nephrology, London, England.
Invited Speaker - Prostate Cancer: Newer Methods of Diagnosis
and Screening, April 14, 1992, Henry County Hospital, New Castle,
Indiana.
Invited Speaker - Diagnosis and Management of Prostate Cancer,
July 11, 1992, Frances Mahon Deaconess Hospital, Glasgow,
Montana.
Invited Speaker - Use of PSA in the Diagnosis and Treatment
of Prostate Cancer, October 10, 1992, Indiana University
Surgery Department, Grand Rounds, Indianapolis, Indiana.
Invited Speaker - Treatment of Prostate Cancer, December 11,
1992, Reid Memorial Hospital, Richmond, Indiana.
Invited Speaker - Thermal Ablation of Canine BPH with Focused
Ultrasound, January 30, 1993, Thermotherapy Workshop, Vienna,
Austria.
Invited Speaker - Status Report - U.S. Phase I Study of
Sonablate for BPH, January 29, 1993, Sonablate European
Study Group, Vienna, Austria.
Invited Speaker – Focused Ultrasound for Treatment of BPH, February
22, 1993, Big Sky Urological Society Conference, Big Sky, Montana.
Invited Speaker - Controversies in Testis Cancer Stage
for Stage, February 20, 1993, Big Sky Urologic Society
Conference, Big Sky, Montana.
Visiting Professor - Focused Ultrasound for Treatment of
BPH, March 2, 1993, Sonablate Workshop, Vancouver General
Hospital, Vancouver, B.C., Canada.
Invited Speaker - High Intensity Focused Ultrasound in
Treatment of BPH, April 10, 1993, Japanese Urological
Association Meeting, Kyoto, Japan.
Invited Speaker - Step Therapy for Benign Prostatic Hyperplasia Utilizing New Treatment Strategies, May 18, 1993,
American Urological Association Meeting, San Antonio, Texas.
Invited Speaker - Prostate Cancer, May 25, 1993, Oncology
Symposium, The Community Hospital, Munster, Indiana.
23
Invited Speaker - Neo-Bladders, June 30, 1993, Indiana
University OR Staff Nurses, Indianapolis, Indiana.
Invited Speaker - Urological Trauma, July 10, 1993, Walleye
Meet, Glasgow, Montana.
Invited Speaker - Focused Ultrasound in Treatment of BPH.
July 29, 1993. Critical Care Conference for Nurses,
Indianapolis, Indiana.
Invited Speaker - Prostate Ablation/BPH. September 22, 1993.
Veterans Hospital OR Nursing Staff, Indianapolis, Indiana.
Invited Speaker - Actual Management of the Germinal Testicular Tumors at the Indiana University in Every Stage.
October 30, 1993. Simposium Internacional De Urologia
Oncologica, Cancun, Mexico.
Invited Speaker - Nerve Sparing in Radical Pelvic Surgery.
October 31, 1993. Simposium Internacional De Urologia
Oncologica, Can-Cun, Mexico.
Invited Speaker - The Urinary Diversions Experience at
Indiana University. October 31, 1993. Simposium Internacional De Urologia Oncologica, Can-Cun, Mexico.
Invited Speaker - Transurethral Focused Ultrasound Ablation
of Prostate. November 6, 1993. 2nd International Congress
of the Dutch Urological Association, Amsterdam, The Netherlands.
Invited Speaker - Controversies in Prostate Cancer. February
9, 1994. First Annual Barnhart Lecture, Deaconess Hospital,
Evansville, Indiana.
Invited Speaker - Evolution of RPLND for Low Stage Disease.
April 6, 1994. Topics in Critical Care: Issues and Strategies
Conference, Department of Nursing, Indiana University Medical
Center.
Invited Speaker - High Intensity Focused Ultrasound (HIFU)Basic Science and Dosimetry. April 14, 1994. 22nd Annual
Symposium on Diseases of the Urinary Tract, Stanford
University, Stanford, California.
Invited Speaker - High Intensity Focused Ultrasound (HIFU)Clinical Application and Results. April 14, 1994. 22nd
Annual Symposium on Diseases of the Urinary Tract, Stanford
University, Stanford, California.
Visiting Professor - Update on Testis Cancer.
May 6, 1994.
24
Medical College of Wisconsin Grand Rounds, Milwaukee, Wisconsin.
Invited Speaker - Update on Prostate Cancer. June 11, 1994.
Indiana Academy of Family Physicians, Indianapolis, Indiana.
Invited Speaker - Predictive Parameters for Biologic Activity
of Early Stage Testis Cancer: New Elements. June 24, 1994.
4th International Symposium on Recent Advances in Urological
Cancer Diagnosis and Treatment. Paris, France.
Invited Speaker - The Analysis of Risk Factors and Patient
Selection for Therapy in Testicular Cancer. June 30, 1994.
5th International Refresher Course in Urology. Copanello,
Italy.
Invited Speaker - Laboratory Correlates in Germ Cell Tumors.
October 8, 1994. Walther Cancer Institute Scientific Retreat.
Indianapolis, Indiana.
Invited Speaker - Prostate Cancer, Detection and Management.
October 14, 1994. Topics in Urology, 1994 Update.
Indianapolis, Indiana.
Invited Speaker – Retroperitoneal Surgery: Indications and Extent.
November 4, 1994. XVI International Cancer Congress. New Delhi,
India.
Invited Speaker - Diagnosis and Treatment of Symptomatic
Benign Prostatic Hyperplasia. January 18, 1995. Medical
Grand Rounds, Wishard Hospital, Indianapolis, Indiana.
Visiting Professor - Secondary Tumors in the Retroperitoneum.
January 19, 1995. University of Arizona, Tucson, Arizona.
Visiting Professor - Controversies in Testis Cancer.
January 20, 1995. University of Arizona, Tucson, Arizona.
Visiting Professor - Complications of Retroperitoneal Lymph
Node Dissection. January 20, 1995. University of Arizona, Tucson,
Arizona.
Invited Speaker - The Management of Benign Prostatic
Hypertrophy. February 23, 1995. Illusions Restaurant,
Indianapolis, Indiana.
Invited Speaker - Current Trends in the Diagnosis and
Treatment of Prostate Cancer. March 1, 1995. Parkview
Memorial Hospital, Fort Wayne, Indiana.
Invited Speaker - Management of Common Office Urological
Problems. May 3, 1995. Farrington House Restaurant,
25
Terre Haute, Indiana.
Invited Speaker - Late Recurrence of Testicular Cancer.
May 12, 1995. Indiana Chapter, American College of Surgeons,
South Bend, Indiana.
Invited Speaker - Diseases of the Scrotum, Testicles, and
Penis. May 17, 1995. Wishard Memorial Hospital, Urgent
Visit Center Faculty Lecture Series, Indianapolis, Indiana.
Invited Speaker - Management of Common Office Urological
Problems. May 18, 1995. Beef House, Covington, Indiana.
Invited Speaker - Dignosis and Treatment of Bladder Cancer.
November 9, 1995. Indiana Cancer Registrars Association,
Fall Conference, Indianapolis, Indiana.
Invited Speaker - Late Relapse of Testis Cancer - New
Parameters to Predict Pathologic Stage in Clinical Stage I.
December 2, 1995. Annual Award Meeting of the C.E. Alken
Prize Winners, Cologne, Germany.
Visiting Professor - Retroperitoneal Lymph Node Dissection
in Clinical Stage II Testis Cancer. December 9, 1995.
International Testis Cancer Symposium, Bonn, Germany.
Visiting Professor - Surgery in Advanced Testis Cancer.
December 9, 1995. International Testis Cancer Symposium,
Bonn, Germany.
Invited Speaker - Focused Ultrasound Ablation of BPH.
January 20, 1996. Minimal Invasive Therapy Workshop, for
Faculty of Indiana University, Purdue University, and Rose
Hulman Institute of Technology, Indianapolis, Indiana.
Invited Speaker - Bladder Cancer. March 20, 1996. Veterans
Hospital Surgical Nurses, Indiana University Medical Center,
Indianapolis, Indiana.
Invited Speaker - Benign Prostatic Hyperplasia. April 27,
1996. Indiana Philippino Medical Society, Greensburg, Indiana.
Visiting Professor - Diagnosis and Management
1996.
Prostate Health Medical Education
Hospital, South Bend, Indiana.
of BPH. August 28,
Program.
Memorial
Visiting Professor - Prostate Pathology and Cancer Update.
August 28, 1996. Prostate Health Medical Education Program.
Memorial Hospital, South Bend, Indiana.
Invited Speaker - Neoadjuvant Hormonal Therapy for Prostate
26
Cancer. October 4, 1996. Controversies in Urologic Cancer.
Division of Continuing Medical Education, Indiana University
School of Medicine, Indianapolis, Indiana.
Invited Speaker - Medical Management of BPH. October 20, 1996.
BPH and Other Urologic Disorders: A Primary Care Perspective,
Westin Hotel, Indianapolis, Indiana.
Invited Speaker - Predictors of Pathological Stage in Clinical
Stage A Testicular Cancer. November 23, 1996. Uro-Oncology
Meeting, New Orleans, LA.
Invited Speaker - Surgical Treatment of Testicular Cancer Nerve Sparing Surgery. November 23, 1996. Uro-Oncology
Meeting, New Orleans, LA.
Invited Speaker - Early Stage Testicular Cancer: A Comparison
of Benefits, Risks and Costs. November 23, 1996. Uro-Oncology
Meeting, New Orleans, LA.
Visiting Professor-Management Options in Low Stage Nonseminomatous
Testis Cancer. November 15, 1996. Sociedad Mexicana de Urologia
Annual Meeting, Puebla City, Mexico.
Peer Review Seminar - Testis Cancer. January 25, 1997. Sponsored by
The Journal of Urology and AUA Office of Education, Dallas,
Texas.
Guest
Moderator
Urologic
Cancer
Forum,
Memorial Hospital , South Bend, Indiana.
January
29,
1997.
Guest Moderator - Adult Testicular Germ Cell Tumors: Prognostic
Factors and Therapeutic Options. International Symposium on
Testicular Cancer, March 8, 1997, Cologne, Germany.
Invited Speaker - Nerve Sparing Retroperitoneal Lymphadenectomy in
Testicular Cancer: Evolution of a Surgical Technique for Low Stage
and High Stage Disease. International Symposium on Testicular
Cancer, March 8, 1997, Cologne, Germany.
Visiting Professor - Surgical Therapy in Testis Cancer: Its Role
and Its Relationship to Medical Oncology. Congress of the Spanish
Association for Cancer Research, May 5, 1997, Oveido, Spain.
Invited Speaker - Prostate Cancer. Nuclear Medicine Group. Indiana
University Hospital, May 20, 1997, Indianapolis, Indiana.
Guest Moderator - Urologic Cancer Forum, Memorial Hospital, May 28,
1997, South Bend, Indiana.
Guest Moderator - Urologic Cancer Forum, Memorial Hospital,
27
July 29, 1997, South Bend, Indiana.
Invited Speaker - The Updated Indiana University Experience
with Nerve Sparing Rplnd: Effective Organ Preserving Therapy.
SIU 24th Congress, September 9, 1997, Montreal, Canada.
Invited Speaker - Surgical Advances in the Treatment of
Testis Cancer. University of Pennsylvania Cancer Center
Conference, September 12, 1997, Philadelphia, Pennsylvania.
Invited Speaker - Testicular Cancer. Knox County Medical
Society Dinner, September 16, 1997, Vincennes, Indiana.
Invited Speaker - Benign Prostatic Hyperplasia. Grand Rounds,
Good Samaritan Hospital, September 17, 1997, Vincennes, Indiana.
Invited Speaker - Testicular Cancer. Urology Nursing Society
Nursing Conference, September 18, 1997, Indianapolis, Indiana.
Guest Moderator - Urologic Cancer Forum, Memorial Hospital,
September 24, 1997, South Bend, Indiana.
Visiting Professor - Current Recommendations for Screening
for Prostate Cancer. Lutheran Hospital, October 7, 1997,
Fort Wayne, Indiana.
Invited Speaker - A Revolutionary System for the Diagnosis
and Management of BPH. Omni Severin Hotel, October 20,
1997, Indianapolis, Indiana.
Invited Speaker - PSA Counts. Indiana Academy of Family
Physicians Hot Topics in Family Medicine CME Conference.
Seasons Lodge & Conference Center, Nashville, Indiana.
October 25, 1997.
Guest Lecturer - Identification of Good Risk Stage I Patients.
The Fourth International Germ Cell Tumour Conference.
Leeds, England, November 13, 1997.
Guest Lecturer - Risk Benefit and Cost Benefit Analysis of
Management Options in Clinical Stage II and Risk Factors in
Clinical Stage III Patients Managed with Post Chemotherapy
RPLND. The Fourth International Germ Cell Tumour Conference.
Leeds, England, November 15, 1997.
Visiting Professor - Controversies in Testicular Cancer. University
Of Illinois at Chicago, Grand Rounds, Chicago, Illinois. November
18, 1997.
Visiting Professor - Benign Prostatic Hyperplasia: New Insights
Into Clinical Management Strategies-The Evolution of Treatment.
28
Rush Presbyterian St. Luke’s Medical Center, Chicago, Illinois.
November 19, 1997.
Session Chairman - Testicular Cancer. The Lance Armstrong
Urologic Oncology Meeting, Newport Beach, California.
November 22, 1997.
Session Chairman - Renal Cell Cancer. The Lance Armstrong
Urologic Oncology Meeting, Newport Beach, California.
November 23, 1997.
Guest Moderator - Urologic Cancer Forum, Memorial Hospital,
South Bend, Indiana, November 26, 1997.
Invited Speaker - Diagnosis and Treatment of Prostate Cancer.
Alcatraz Brewing Company, Indianapolis, Indiana. December
2, 1997.
Invited Speaker - Current Issues in Prostate Cancer. Kellogg Hotel
and Conference Center, Lansing, Michigan. December 16, 1997.
Guest Moderator - Urologic Cancer Forum, Memorial Hospital,
South Bend, Indiana. January 28, 1998.
Invited Speaker - Drug Therapy in BPH and Hormone Refractory
Prostate Cancer. Fort Wayne Urology Group, Fort Wayne, Indiana.
February 12, 1998.
Visiting Professor - Treatment of Testicular Tumors. Northwestern
Ohio Urological Association Meeting, Toledo, Ohio. March 3, 1998.
Invited Speaker - Controversies in Stage I-II Testis Cancer.
Fellows’ Oncology Lecture, Department of Oncology, Indiana
University Medical Center, Indianapolis, Indiana. March 16, 1998.
Guest Moderator - Urologic Cancer Forum, Memorial Hospital,
South Bend, Indiana. May 27, 1998.
Visiting Professor - Renal Cell Carcinoma. St. Mary’s Medical
Center, Evansville, Indiana. June 17, 1998.
Guest Moderator - Urologic Cancer Forum, Memorial Hospital,
South Bend, Indiana. July 29, 1998.
Invited Speaker - Benign Prostatic Hyperplasia. Urology
Association, LLC, Muncie, Indiana. September 9, 1998.
Invited Speaker - Management of Long Term Treatment Outcomes.
Basils on the Race, South Bend, Indiana. September 29, 1998.
Guest Moderator - Urologic Cancer Forum, Memorial Hospital,
29
South Bend, Indiana.
September 30, 1998.
Invited Speaker - Renal Cell Carcinoma. Surgical Grand Rounds,
Wishard Memorial Hospital, October 8, 1998.
Co-Chairman - Renal Cell Cancer Session, The Lance Armstrong
Urologic Oncology Meeting, McLean, Virginia. October 25, 1998.
Co-Chairman - Testis Cancer Session, The Lance Armstrong Urologic
Oncology Meeting, McLean, Virginia. October 25, 1998.
Presenter - Residual Mass in Seminoma. The Lance Armstrong
Urologic Oncology Meeting, McLean, Virginia. October 25, 1998
Invited Speaker - An Update on Prostate Cancer.
Michigan City, Indiana. January 28, 1999.
Blue Chip Casino,
Invited Speaker - A Cure for Testis Cancer: Our 25 Year Success
Story.
Indiana University Mini Medical School, Indianapolis,
Indiana. February 23, 1999.
Invited Speaker - Lymphadenectomy in Testis Neoplasm.
International Urology Course, “Developments in Urology ‘99",
Barcelona, Spain. March 3, 1999.
Invited Speaker - Indications and Limits of Radical Treatment of
In Situ Cancer. International Urology Course, “Developments in
Urology ‘99", Barcelona, Spain, March 3, 1999.
Guest Moderator - Urologic Cancer Forum, Memorial Hospital,
South Bend, Indiana. March 24, 1999.
Invited Speaker - Management of Clinical Stage II A/B Nonseminoma:
Primary Surgery vs. Chemotherapy. IUCC-Symposium on Testicular
Cancer, Tuebingen, Germany, March 19, 1999.
Invited Speaker - Management of Residual Tumors after Chemotherapy:
Salvage Surgery. IUCC-Symposium on Testicular Cancer, Tuebingen,
Germany, March 20, 1999.
Invited Speaker - Current Therapy in the Management of Benign
Prostatic Hypertrophy. Medical Education Seminar, Gibson County
Hospital, Princeton, Indiana. May 18, 1999.
Visiting Professor - Prostate Cancer-Overview of Management-Early
Stages.
Tumor Board Conference, St. Joseph’s Medical Center,
Plymouth, Indiana, April 8, 1999.
Visiting Professor - Options in the Management of Clinical Stage
I Nonseminomatous Testis Cancer.
Marshfield Clinic, Marshfield,
Wisconsin, June 25, 1999.
30
Visiting Professor - Current Surgical Issues in the Management of
Metastatic Testis Cancer. Marshfield Clinic, Marshfield,
Wisconsin, June 25, 1999.
Invited Speaker - Indications and Timing for Cytoreductive Surgery
In Relation to Chemotherapy in Testis Cancer (Surgery before or
After Chemo, Residual Mass Retrieval, Lymphadenectomy or
Tumorectomy. Sociedad Mexicana De Urologia Meeting, Alcapulco,
July 15, 1999.
Invited Speaker - Advantages and Disadvantages of the New
Techniques for RPLND. Sociedad Mexicana De Urologia Meeting,
Alcapulco, July 15, 1999.
Invited Speaker - Point-Counter Point: Surgery Versus Chemotherapy
Surveillance in NSGT Stage I Testis Cancer. Sociedad Mexicana De
Urologia Meeting, Alcapulco, July 15, 1999.
Invited Speaker - Is There Such A Thing as Clinically NonSignificant Prostate Cancer? Sociedad Mexicana De Urologia
Meeting, Alcapulco, July 16, 1999.
Invited Speaker - Urologic Cancer Forum,
Bend, Indiana, September 29, 1999.
Memorial
Hospital,
South
Invited Speaker - Urologic Cancer Forum, Memorial Hospital, South
Bend, Indiana, November 24, 1999.
Invited Speaker - Urologic Cancer Forum,
Bend, Indiana, January 26, 2000.
Memorial
Hospital,
South
Invited Speaker - 27th Annual Big Sky Urology Conference, Billings,
Montana, March 15-18, 2000.
Guest Moderator - Annual Meeting of American Urological Association,
Atlanta, Georgia, May 1, 2000.
Invited Speaker - Los Angeles Urological
California, September 19, 2000
Society,
Los
Angeles,
International Symposium of Oncology, “Advances in Diagnosis and
Treatment of Prostate Cancer,” Marburg, Germany, October 20-21,
2000.
Invited Speaker – Urological Cancer Forum, South Bend, Indiana,
November 29, 2000.
Invited Speaker - First Annual Meeting of Urological Oncology,
Bethesda, Maryland, December 2-3, 2000.
31
Invited Speaker - I.U. Visiting Professor Program, Union Hospital,
Terre Haute, Indiana, December 15, 2000.
Invited Speaker - Urological Cancer Forum, South Bend, Indiana,
March 28, 2001.
Invited Speaker - West Michigan Urologic
Grand Rapids, Michigan, May 2, 2001.
Society
Spring
Meeting,
Invited Speaker - Plenary Session - Annual Meeting of
Urological Association, Anaheim, California, June,2001
American
Invited Speaker - Urological Cancer Forum, South Bend, Indiana,
July 25, 2001.
Invited Speaker - Urological Cancer Forum, South Bend, Indiana,
September 26, 2001.
Visiting Professor – Indiana University Visiting Professor Program,
Bluffton, Indiana, December 12, 2001.
Visiting Professor - Robert Bahnson Visiting Professor, Ohio State
University, Columbus, OH, February 19, 2002.
Invited Speaker - Chicago Urological Society Meeting, Chicago, IL,
March 6, 2002.
Guest Moderator - Symposium in Honor of Lawrence H. Einhorn, M.D.,
Indianapolis, Indiana, April 20, 2002.
Invited Speaker - Urological Cancer Forum, South Bend, Indiana,
September 25, 2002.
Invited Speaker – Michigan Urological Society, Royal Oak, Michigan,
October 16, 2002.
Invited Speaker - Urological Cancer Forum, South Bend, Indiana,
January 29, 2003.
Invited Speaker – National Urologic Oncology
Beach, California, February, 2003.
Update
2003,
Newport
Invited Speaker – Urological Cancer Forum, South Bend, Indiana, March
26, 2003.
State-of-the-Art Presenter – Plenary Session, 2003 Annual Meeting of
the American Urological Association, Chicago, Illinois, April 28,
2003.
Invited Speaker – Urological Cancer Forum, South Bend, Indiana, May
32
28, 2003.
Invited Speaker – Annual Meeting of American
Oncologists, Chicago, IL, May 31, 2003.
Society
of
Clinical
Invited Speaker – Urological Cancer Forum, South Bend, Indiana, July
30, 2003.
Invited Speaker – 2003 Annual Clinical Assembly
Specialists, Chicago, IL, September 19, 2003.
of
Invited Speaker – Urological
September 24, 2003.
Bend,
Cancer
Forum,
South
Osteopathic
Indiana,
Presenter, Live Surgery Demonstration – 6th International Symposium on
Uro-Oncology, Marburg, Germany, October 23-25, 2003.
Invited Participant – Technology Assessment Workshop:
Comparison of
Standard Open and Laparoscopic Retroperitoneal Lymphadenectomy for
Testis Cancer. Toronto, Canada, November 20-21, 2003.
Invited Speaker – Grand Rounds, University of Illinois at Chicago,
Chicago, IL, March 17, 2004.
Invited Speaker – Urological Cancer Forum, South Bend, Indiana, July
28, 2004.
Invited Speaker – Urological
September 29, 2004.
Cancer
Invited Speaker – Grand Rounds,
Indiana, November 3, 2004.
Invited Speaker – Urology
November 11, 2004.
Invited Speaker – Swiss
November 19, 2004.
Nursing
Society
Invited Speaker - Urological
January 25, 2005.
Reid
of
Cancer
Forum,
South
Memorial
2004,
Bend,
Indiana,
Hospital,
Richmond,
Indianapolis,
Indiana,
Urology,
Forum,
Lucerne
South
Switzerland,
Bend,
Indiana,
Invited Speaker – Big Sky Urology Conference, Billings, MT, March,
2005
Visiting Professor – Israeli Uro-Oncology Society, Tel Aviv, Israel,
April, 2005.
Invited Speaker – Annual Meeting of American
Oncologists, Orlando, FL, May, 2005.
Society
of
Clinical
33
Take Home Message Presenter – Annual Meeting of AUA, San Antonio, TX,
May, 2005.
Invited Speaker – First Annual Oncology World Congress, New York,
N.Y., November, 2005.
Invited Speaker – Urologic Cancer Forum, South Bend, Indiana, November
30, 2005
Invited Speaker – Sixth Annual SUO Meeting, Bethesda, MD, December,
2005.
Invited Speaker – Urologic Cancer Forum, South Bend, Indiana, January
25, 2006.
Invited Speaker – Advances in Uro-Oncology: Eine Festschrift for Dr.
Horst Zincke, Mayo Clinic, Rochester, MN, April 29, 2006.
Jordan Brown Visiting Professor – New York University, New York, N.Y.,
March 7, 2007.
Invited Speaker – 2007 Specialty Review in Urology, Chicago, IL, Apr.
29, 2007.
Invited Speaker – Urologic
September 26, 2007.
Cancer
Forum,
South
Bend,
Indiana,
Invited Speaker – Surgical, Pharmacological and Technological Advances
in Adult and Pediatric Urology State of the Art, NY,NY, December
6-8, 2007.
Invited Speaker – The University of Chicago
Urology, Chicago, IL, April 8, 2008.
Specialty
Review
in
Invited Speaker – Urologic Cancer Forum, South Bend, Indiana, May 28,
2008.
Invited Speaker – Urologic
September 24, 2008.
Cancer
Forum,
South
Bend,
Indiana,
Invited Speaker – Oncology Congress, San Francisco, CA, September 27,
2008.
Invited Speaker – Puerto Rico Urological Association, November 13-15,
2008.
Keynote Speaker – Prairie
Canada, March 6, 2009.
Urologic
Association
Invited Speaker – The University of Chicago
Urology, Chicago, IL, April 6, 2009.
Meeting,
Specialty
Alberta,
Review
in
34
Guest Moderator – Annual Meeting of American Urological Association,
Chicago, IL, April 27, 2009.
Visiting Professor – Beth Israel, NY, NY, May 15, 2009.
Invited Speaker – Urologic Cancer Forum, South Bend, Indiana, May 27,
2009.
Invited Speaker – Urologic
September 23, 2009.
Cancer
Forum,
South
Bend,
Indiana,
Invited Speaker – Kaiser Permanente National Urology Symposium – Del
Mar, CA, September 25-26, 2009.
Invited Speaker – Annual Meeting of Indiana Surgical Technologists
Group, October 24, 2009.
Panel Discussion – Controversial Cases in Testis Cancer – North
Central Section of the AUA, Scottsdale, AZ, November 11, 2009.
Invited Speaker – SUO 10th Annual Meeting, Bethesda, MD, December 2-4,
2009.
Invited Speaker – Big Sky Urology Conference, Big Sky, Montana, March
4-6, 2010.
Invited Speaker – Specialty Review in Urology, Chicago, IL, April 28,
2010.
Guest Moderator – AUA Annual Meeting, San Francisco, CA, May 28 – June
1, 2010.
CHAPTERS
Complications of Retroperitoneal Lymph Node Dissection. Bihrle, R.,
Donohue, J.P., and Foster, R.S. UROLOGIC CLINICS OF NORTH AMERICA,
J. Libertino (ed), Vol. 15:2, pp. 237-242, W.B. Saunders,
Philadelphia, 1988.
Retroperitoneal Lymphadenectomy.
Foster, R.S., Donohue, J.P., and
Bihrle, R.
OPERATIVE UROLOGY, ed. FF Marshall, p. 100-108, W.B.
Saunders, 1991.
Continent Ileocecal Reservoirs:
The Indiana Pouch.
Bladder
Reconstruction and Continent Urinary Diversion.
Bihrle, R. and
Foster, R.S.
L.R. King, A.S. Story, G.D. Webster (eds.), pp.
308-315, MOSBY YEARBOOK, 1991.
35
Update on the Indiana Continent Urinary Reservoir.
Rowland, R.G.,
Bihrle, R., Scheidler, D., Foster, R.S., and Klee, L.W. PROBLEMS IN
UROLOGY, David Paulson (ed), pp. 269-282, J.B. Lippincott Co.,
Philadelphia, 1991.
Transverse Colon Gastric Tube Composite Reservoir. Bihrle, R., Klee,
L.W., and Foster, R.S. PROBLEMS IN UROLOGY, David Paulson (ed), pp.
292-298, J.B. Lippincott Co., Philadelphia, 1991.
Nonseminomatous Germ Cell Tumor.
Foster, R.S. and Donohue, J.P.
CURRENT THERAPY IN GENITOURINARY SURGERY, Martin Resnick (Ed.), pp.
173-176, B.C. Decker, 1992.
Bilateral and Modified Nerve-Sparing Retroperitoneal Lymphadenectomy
for Testicular Cancer. Foster, R.S. and Donohue, J.P. MASTERY OF
SURGERY: UROLOGY, Jackson Fowler (ed.), Little, Brown & Co., 1992.
Retroperitoneal Lymph Nodes and Masses.
Donohue, J.P. and Foster,
R.S.
Surgical Management of Urologic Disease, Michael Droller
(ed.), MOSBY YEARBOOK, pp. 518-536, 1992.
Evolving Concepts in Surgical Management of Testis Cancer. Donohue,
J.P., Bihrle, R., and Foster, R.S.
THERAPY FOR GENITOURINARY
CANCER, Kluwer Academic Publishers, pp. 89-97, 1992.
Testicular Tumor.
Foster, R.S., Donohue, J.P., Bihrle, R., and
Rowland, R.G.
PRACTICE OF UROLOGY, W.W. Norton & Co., Vol. 2,
Chapter 7, 1992.
Radical Retroperitoneal Lymph Node Excision.
Foster, R.S. and
Donohue,
J.P.
GENITOURINARY
SURGERY,
Hugh
Whitfield,(ed.),
Butterworth-Heinemann Ltd. Vol. 2, pp. 577, 585, 1993.
Nerve-Sparing Retroperitoneal Lymphadenectomy.
Foster, R.S. and
Donohue, J.P. THE UROLOGIC CLINICS OF NORTH AMERICA, E.A. Klein &
R. Kay, (eds.) W.B. Saunders Co. Vol. 20, No. 1, February, 1993.
A
Preliminary Report: Postoperative Fertility Assessment in Nerve
Sparing RPLND Patients. Foster, R.S., Bennett, R., Bihrle, R., and
Donohue, J.P. In: MANAGEMENT OF BIOLOGY OF CARCINOMA IN SITU AND
CANCER OF THE TESTIS. Ed: N.E. Skakkebach, K.M. Grigor, A.
Giwercman, and M. Rorth.
Proceedings of 3rd Copenhagen Workshop.
Berne, Switzerland. 23:165-168, 1993.
Nerve-Sparing RPLND.
Foster, R.S. and Donohue, J.P. AUA Update
Series, American Urological Association, Vol. XII, Lesson 15, 1993.
Clinical Stage and Residual Tumor after Chemotherapy as a Prognostic
Factor in Testicular Cancer. Donohue, J.P., Foster, R.S., Loehrer,
P., Ulbright, T., deReise, W., deReise, C., and Walker, E.
PROGNOSTIC FACTORS IN UROLOGICAL CANCERS, J.Breul; R.Hartung (ed)
36
Zuckschwerdt 1993 (Aktuelle Onkologie;78)
Retroperitoneale
Lymphadenektomie
(RPLA)-Nervenerhaltende
Opertionstechnik. Foster, R.S., Donohue, J.P., Albers, P., and
Voges, G.E.
In: AKTUELLE UROLOGIE OPERATIVE TECHNIKEN. R.
Hohenfellner, R. Nagel, E. Zingg, G. Thieme (eds) Verlag Stuttgart,
Germany. 1-10, 1993.
Management of Testis Cancer.
Foster, R.S. and Donohue, J.P.
MANAGEMENT OF UROLOGIC DISORDERS, R. Bahnson (ed)
Mosby Yearbook,
Chapt. 6, Wolfe Publishing, 1994, London, England.
Retroperitoneal Lymphadenectomy
Modifications of Technique and
and Foster, R.S.
PROBLEMS
Lippincott Co., Philadelphia,
for Clinical Stage A Testis Cancer:
Impact on Ejaculation. Donohue, J.P.
IN UROLOGY, D. Paulson (ed) J. B.
Vol. 8, No. 1, 1994.
High Intensity Focused Ultrasound Treatment of Human BPH. Foster,
R.S., Bihrle, R., Sanghvi, N.T., Donohue, J.P., and Fry, F.J.
BENIGN PROSTATIC HYPERPLASIA, K. Kurth and D. Newling (ed)
Wiley-Liss, New York, Vol. 386, pp. 463-471, 1994.
Residual Lymphadenopathy after Surgery, Chemotherapy,or Radiation
Therapy.
Foster, R.S. and Donohue, J.P. REOPERATIVE UROLOGY, Marc
Cohen and Martin Resnick (eds). Little, Brown & Co., Boston, 1994.
Management of Retroperitoneal Recurrences:
Seminoma and Nonseminoma.
Donohue, J.P. and Foster, R.S.
UROLOGY CLINICS OF NORTH AMERICA,
Martin Resnick (ed). W.B. Saunders Co., Philadelphia, Vol. 21, #4,
pp. 761-772, 1994.
Predictive Parameters for Biologic Activity of Early Stage Testis
Cancer: New Elements.
Foster, R.S., Albers, P., DeRiese, W.T.,
Miller, G., et al.
4TH INTERNATIONAL SYMPOSIUM ON RECENT ADVANCES
IN UROLOGICAL CANCER DIAGNOSIS AND TREATMENT PROCEEDINGS, G. Murphy,
S. Khoury, C. Chatelain, L. Denis (eds).
Scientific Communication
International Ltd., Channel Islands, #4, pp. 521-527, 1994.
Fertility in Testicular Cancer Patients.
Foster, R.S., and Donohue,
J.P. AUA Update Series, American Urological Association, Vol. XIV,
Lesson 19, 1995.
Testicular Tumor.
Foster, R.S., Bihrle, R., Donohue, J.P., and
Rowland, R.G.
CLINICAL UROLOGIC PRACTICE, Barry Stein (ed)
W.W.
Norton & Co, New York, pp. 1027-1039,1995.
Adaptations of the Mitrofanoff Principle in Adult Continent Urinary
Reservoirs.
Bihrle, R., Adams, M.C., and Foster, R.S.
TECHNIQUES
IN UROLOGY, David Albala & Leonard Gomella (eds)
Lippincott-Raven
Publishers, Philadelphia, pp. 94-101, 1995.
Use of the Ileocecal Segment and Right Colon in Continent Diversion
37
and Bladder Replacement. Bihrle, R. and Foster, R.S. ATLAS OF THE
UROLOGY CLINICS OF NORTH AMERICA, John Libertino & Peter Nieh (eds)
W.B. Saunders, Philadelphia, Vol. 3, #2, pp. 29-44, October, 1995.
Retroperitoneal Lymph Node Dissection.
Foster, R.S., and Donohue,
J.P.
COMPREHENSIVE TEXTBOOK OF GENITO-URINARY ONCOLOGY, N.
Vogelzang, P. Scardino, W. Shipley, and D. Coffey (eds) Williams &
Wilkins, Philadelphia, pp. 996-1002, 1995.
Flubzytometrische und Zytophotometrische DNA-Analyse zur Vorhersage
okkulter Metastasen im Klinischen Stadium Ades Nicht-Seminomatosen
Hodentumors. Albers, P., W.T. deRiese, E.B. Walker, T.M. Ulbright,
C. deRiese, R.S. Foster, J.P. Donohue. HODENTUMOREN/TESTIS CANCER,
D.
Schnorr,
S.A.
Loening,
L.
Weisbach
(eds)
Blackwell
Wissenschaftsverlag, Berlin, pp. 194-195, 1995.
Ein
neuer
Proferationsmarker
(MIB-1)
zur
Vorhersage
Okkulter
Metastasen bei Hodentumoren (NSGCT) im Klinischen Stadium A.
Albers, P., Orazi, A., Ulbright, T.M., Foster, R.S., and Donohue,
J.P.
HODENTUMOREN/TESTIS CANCER, D. Schnorr, S.A. Loening, L.
Weisbach (eds) Blackwell Wissenschaftsverlag, Berlin, pp. 195-196,
1995.
Scrotum & Testis.
Rowland, R.G., Foster, R.S., and Donohue, J.P.
ADULT & PEDIATRIC UROLOGY, 3nd Ed., Gillenwater, J.Y., Grayhack,
J.T., Howards, S.S., and Duckett, J.W. (eds) Mosby Yearbook, Inc.,
St. Louis, Chapt. 39, pp. 1917-1949, 1996.
High Intensity Focused Ultrasound in the Treatment of Prostatic
Disease.
Bihrle, R., Foster, R.S., and Sanghvi, N.T.
TOPICS IN
CLINICAL UROLOGY: TECHNIQUES FOR ABLATION OF BENIGN AND MALIGNANT
PROSTATE TISSUE. J.A. Smith, Jr. and D.F. Milam (eds)
Igaku-Shoin
Medical Publishers, New York, Chapt. 12, pp. 173-188, 1996.
Retroperitoneal Lymphadenectomy.
Foster, R.S., Donohue, J.P., and
Bihrle, R. TEXTBOOK OF OPERATIVE UROLOGY. F.F. Marshall (ed) W.B.
Saunders Co., Philadelphia Chapt. 44, pp. 365-372, 1996.
Neoplasms of the Testis. Nichols, C.R., Timmerman, R., Foster, R.S.,
Roth, B.J., and Einhorn, L.H. CANCER MEDICINE, 4TH EDITION. J.F.
Holland, R.C. Bast, Jr., D.L. Morton, E. Frei III, D.W. Kufe, and
R.R. Weichselbaum (eds) Williams & Wilkins, Baltimore, Chapt. 128,
pp. 2177, 1996.
Cytoreductive Surgery for Nonseminomatous Germ Cell Cancer. Donohue,
J.P., Foster, R.S., Rowland, R.G., and Bihrle, R.
PRINCIPLES AND
PRACTICE OF GENITOURINARY ONCOLOGY
D. Raghavan, H.I. Scher, S.A.
Leibel,
and
P.H.
Lange
(eds)Lippincott-Raven
Publishers,
Philadelphia, Chapt. 70, 1996.
Cancer de Testiculo: Estado Actual del Tratamiento. Foster, R.S. and
38
Donohue, J.P.
TUMORES UROLOGICOS. J. Cruz and C.D. Vera Donoso
(eds) Grupo Aula Medica, S.A., Madrid, Chapt. 13:195-201, 1996
Adjuvant Surgery for Residual Disease in Patients With Germ Cell
Testis Tumor. Foster, R.S. and Donohue, J.P. In: ADJUVANT TREATMENT
IN UROLOGICAL CNCER. A.S. Abi-Aad (ed) The Parthenon Publishing
Group, New York, pp. 301-316, 1997.
Malignant Tumors of the Urogenital Tract. Foster, R.S. In:
CONN’S CURRENT THERAPY. R.E. Rakel (ed) W.B. Saunders Co.,
Philadelphia,pp. 715-722, 1998.
Identification of Good Risk Stage I Patients. Foster, R.S. &
Donohue, J.P. In: GERM CELL TUMOURS IV. W.G. Jones, I.
Appleyard, P. Harnden & J.K. Joffe (eds) John Libbey &
Co.,Ltd., London, pp. 165-170, 1998.
Risk Benefit and Cost Benefit Analysis of Management Options in
Clinical Stage II and Risk Factors in Clinical Stage III Patients
Managed with Post Chemotherapy RPLND. Foster, R.S. & Donohue, J.P.
In: GERM CELL TUMOURS IV. W.G. Jones, I. Appleyard, P. Harnden, &
J.K. Joffe (eds) John Libby & co., Ltd., London, pp 285-290, 1998.
Can Retroperitoneal Lymphadenectomy Be Omitted in Some Patients
After Chemotherapy? Foster, R.S. & Donohue, J.P. In: UROLOGIC
CLINICS OF NORTH AMERICA. P.R. Carroll & J.C. Presti, Jr. (eds)
W.B. Saunders, Philadelphia, pp. 479-484, 1998.
Testicular Tumors. Foster, Richard S. In: PROGNOSIS AND
OUTCOMES IN SURGICAL DISEASE. Daniel P. McKellar, Richard B.
Reiling, Ben Eiseman. (eds) Quality Medical Publishing, Inc.,
Louis, pp. 278-279, 1999.
St.
High-Intensity Focused Ultrasound. Foster, Richard S., Bihrle,
Richard, Sanghvi, Narendra T. In: PROSTATIC DISEASES. Herbert
Lepor. (ed) W.B. Saunders Co., Philadelphia, pp. 293-296, 2000.
Retroperitoneal Lymph Node Dissection. Foster, Richard S. and
Donohue, John P. In: GENITOURINARY ONCOLOGY. Nicholas J.
Vogelzang, Peter T. Scardino, William U. Snipley, Donald
S.Coffey.(eds) Lippincott Williams & Wilkins, Philadelphia, pp. 955961, 2000.
Radical Retroperitoneal Lymph Node Dissection. Foster, Richard S. and
Donohue, John P. In: Operative Urology: Surgical Skills. Robert J.
Krane, Mike B. Siroky, and John M. Fitzpatrick. (eds) Churchill
Livingstone, Philadelphia, 2000.
Neoplasms of the Testis. Nichols, Craig R., Timmerman, Robert, Foster,
Richard S., Roth, Bruce J., and Einhorn, Lawrence H. In: CANCER
MEDICINE, Fifth Edition. Robert C. Bast, Jr., Donald W. Kufe,
39
Raphael E. Pollock, Ralph R. Weichselbaum, James F. Holland, Emil
Frei, III, and Ted S. Gansler. (eds) B.C. Decker, Inc., Hamilton,
Ontario, 2000.
Surgery for Germ Cell Tumours: Current Status in the USA. Foster,
R.S., Bihrle, R., Donohue, J.P. In: Germ Cell Tumours V. P.
Harnden, J.K. Joffe and W.G. Jones (eds) Springer-Verlag London Ltd,
Great Britain, 2002.
Testicular Cancer. Surgical
Foster, R.S. and Donohue,
Malignancies. Freddie C.
William J. Catalona (eds)
Treatment and Treatment of Seminomas.
J.P. In: Management of Urologic
Hamdy, Joseph W. Basler, David E. Neal,
Churchill Livingstone, London, 2002.
Urogenital complications. DeMarco, R.T. and Foster, R.S. In:
Handbook of Advanced Cancer Care. Michael J. Fisch and Eduardo
Bruera (eds) Cambridge University Press, Cambridge U.K., 2003.
Testis Cancer Update 2003 – Management Options for Clinical Stage I
Nonseminoma and Post Chemotherapy Retroperitoneal Lymph Node
Dissection. Foster, R.S. In: American Society of Clinical
Oncology Educational Book. Michael C. Perry (ed) American Society
of Clinical Oncology, 2003.
Surgery of the Retroperitoneum. Foster, R.S., Bihrle, R., and
Donohue, J.P. In: Germ Cell Tumors, Derek Raghavan, M.D., PhD.
(ed) In: American Cancer Society Atlas of Clinical Oncology. Glenn
D. Steele, Jr., M.D., Theodore L. Phillips, M.D., Bruce A. Chabner,
M.D., and Ted S. Gansler, M.D., MBA (eds) BC Decker Inc., Hamilton,
London, 2003.
Radical Orchiectomy and Retroperitoneal Lymph Node Dissection.
Foster, R.S., Mosharafa, A., Bihrle, R. In: Urologic Oncology.
Jerome P. Richie, M.D. and Anthony V. D’Amico, M.D. (eds) Elsevier
Saunders, Philadelphia, PA, 2005.
Surgery versus chemotherapy for high risk NSGCT: why surgery? Foster,
R.S. In: The Evidence for Urology. Chris Dawson & Gordon Muir
(eds) Gutenberg Press Ltd., Malta, 2005.
Seminomatous Testicular Carcinoma and Nonseminomatous Testicular
Carcinoma. Foster, R.S. In: Clinical Scenarios in Surgical
Oncology. Vijay P. Khatri, M.D., FACS (ed) Lippincott Williams &
Wilkins, Philadelphia, PA, 2006.
Radical Orchiectomy and Retroperitoneal Lymph Node Dissection.
Foster, R.S., Bihrle, R., and Donohue, J.P. In: Comprehensive
Textbook of Genitourinary Oncology. Nicholas J. Vogelzang, M.D.,
Peter T. Scardino, M.D., William U. Shipley, M.D., Frans M.J.
Debruyne, M.D., Ph.D., and W. Marston Linehan, M.D. (eds)
Lippincott Williams & Wilkins, Philadelphia, PA, 2006.
40
Nervenerhaltende Retroperitoneale Lymphadenektomie. Albers, P.,
Foster, R.S., Voges, G.E., Donohue, J.P. In: Standardoperationen
in der Urologie. Peter Albers, M.D. and Axel Heidenreich, M.D.
(eds.) Thieme, Stuttgart, 2006.
Testis Cancer. Nichols, C.R., Hung, A., Corless, C.L., Foster, R.S.,
Roth, B.J., Einhorn, L.E. In: Holland-Frei Cancer Medicine 7.
Donald W. Kufe, M.D., Robert C., Bast Jr., M.D., William N. Hait,
M.D., Ph.D., Waun Ki Hong, M.D., Raphael E. Pollock, M.D., Ph.D.,
Ralph R. Weichselbaum, M.D., James F. Holland, M.D., Sc.D. (hc),
Emil Frei III, M.D. (eds) BC Decker Inc., Hamilton, Ontario, 2006.
Retroperitoneal Lymph Node Dissection in Testicular Cancer. Jacobsen,
N.B., Foster, R.S., Donohue, J.P. In: Surgical Oncology Clinics of
North America. Lymphadenectomy in Surgical Oncology: Staging and
Therapeutic Role. Vijay P. Khatri, MBChB, FACS and Nicholas J.
Petrelli, M.D. (eds) Saunders, Philadelphia, PA, 2007.
Post Chemotherapy RPLND in Patients with Elevated Markers: Current
Concepts and Clinical Outcome. Beck, S.D.W., Foster, R.S., Bihrle,
R., Einhorn, L.H., and Donohue, J.P. In Urologic Clinics of North
America, Testicular Cancer. Joel Sheinfeld, M.D. and Martin I.
Resnick, M.D. (eds) W.B. Saunders Company, Philadelphia, PA, 2007.
RESEARCH
Richard Bihrle, Principal Investigator. Investigators at
Indiana University for Eli Lilly & Co. Quinelerane HCL, An
Investigational New Drug. 1988.
Richard Bihrle, Principal Investigator. Investigators at
Indiana University for the FDA Trial of the Wolf
Piezoelectric Lithotriptor, 1988.
Richard S. Foster, Principal Investigator. Longitudinal
Studies of Semen Quality in Men with Primary Testis
Cancer. American Cancer Society, July, 1988, $5000.00.
Richard S. Foster & Leslie Rubin, Co-Principal Investigators
Elucidation of Sperm Associated Fertility Potential in
Men with Carcinoma of the Testis. Indiana University
Grant-in-Aid Type I Grant, May, 1989, $22,100.00.
Richard Bihrle, Principal Investigator. Investigators
at Indiana University for A.M.S. Prostatic Balloon
Dilation Device, 1989.
Richard Bihrle, Principal Investigator.
Investigators
41
at Indiana University for Initial U.S. Studies of the
A.M.S. Urethral Stent, 1989. (IUPUI Study #8812-09)
Richard S. Foster, Principal Investigator. Prostate Ablation
Project with ICFAR and Diasonics, 1990.
Richard Bihrle, Principal Investigator. Treatment of Benign
Prostatic Hypertrophy Symptoms Using the Wallstent HoldOpen Stent. August, 1990. (IUPUI Study #9007-16)
John Mulcahy, Principal Investigator.
Investigators
at Indiana University for Treatment with SK&F 105657 on
Prostatic and Serum Dihydrotestosterone Levels in
Patients with BPH, 1991.
Richard S. Foster, Principal Investigator. Transrectal
Ultrasound Ablation of Prostatic Tissue. Diasonics
Corporation and Indiana Center for the Development of
Advanced Research. May, 1991. $80,000.00.
Richard S. Foster, Principal Investigator. VA Cooperative
Study: A Clinical Trial Comparing the Safety and
Efficacy of Alpha Blockade and Androgen Suppression
for the Treatment of BPH, 1992.
Paper published from above study: The Efficacy of Terazosin,
Finasteride, or both in Benign Prostatic Hyperplasia. Lepor,
H., Williford, W.O., Barry, M.J., Brawer, M,K., etal. New Eng.
J. Med., 335:533-539, 1996.
Richard S. Foster, Principal Investigator. VA Cooperative
Study: A Clinical Trial Comparing the Safety and Efficacy
of Alpha Blockade and Androgen Suppression for the
Treatment of BPH. October, 1992. $124,562.00.
VA Cooperative Study: A Clinical Trial Comparing the Safety
and Efficacy of Alpha Blockade and Androgen Suppression
for the Treatment of BPH. Richard S. Foster, M.D.,
Principal Investigator, October, 1992, $124,562.00.
Richard S. Foster, Principal Investigator. Clinical
Evaluation of the Sonoblate Ultrasonic Prostatic Ablation
System for Benign Prostatic Hyperplasia. June, 1993.
(IUPUI Study #9305-05)
Richard S. Foster, Principal Investigator. VA Cooperative
Study #407: Prostate Cancer Intervention Versus
Observation Trial (PIVOT): A Randomized Trial Comparing
Radical Prostatectomy Versus Palliative Expectant
Management for the Treatment of Clinically Localized
42
Prostate Cancer.
year.
August, 1994.
$27,000 + $20,000 per
Richard Bihrle, Principal Investigator. Post Approval
Urolume Endoprosthesis for Recurrent Bulbar Urethral
Stricture Study, June, 1996. (IUPUI Study #9605-15)
Richard Foster, Principal Investigator. Protocol A9303:
A Phase II Study: (A9303) Intravesical AS 32 in Patients
with Transitional Cell Carcinoma of the Bladder. October,
1996. (IUPUI Study #9607-03) Anthra Pharmaceuticals, Inc.
Richard Foster, Principal Investigator. Protocol A930:
A Phase II Study (A9301) Intravesical AD 32 in Patients
with Carcinoma In Situ of the Bladder who Have Failed or
have Recurrence Following Treatment with BCG. November,
1996. (IUPUI Study #9607-04) Anthra Pharmaceuticals,
Inc.
Richard Bihrle, Principal Investigator. Post Approval Study
for the Urolume Endoprosthesis for Treating Recurrent
Bulbar Urethral Stricture Disease. December, 1996.
(IUPUI Study #9611-08) American Medical Systems.
Brian Giesler, Principal Investigator. Quality of Life in
Radical Prostatectomy Patients and Spouses/Partners Following
PSA Failure. American Cancer Society, 1999-2001, $242,000.00.
COMMUNITY SERVICE
Lecture on Urinary Incontinence and Obstruction. Near Eastside
Multi-Service Center, Indianapolis, Indiana,April 23, 1991.
Participation in locally produced television show called "Second
Opinion" with Dr. Patrick Loehrer. Discussion concerning cancer
related issues, 1992.
Lecture on Urinary Changes in the Aging. Southeast Multi-Service
Center, Indianapolis, Indiana, April 12, 1994.
Lecture on Prostate Cancer. St. Paul’s Episcopal Church,
Indianapolis, Indiana. January 11, 1998.
Presentation for Kidney Cancer Association, Education and Support
Meeting, Four Points by Sheraton, Indianapolis, Indiana. February 9,
2002.
Presentation at Mini Medical School, “Updates in Testis Cancer
Management”, Indianapolis, Indiana. October 16, 2003.
43
Moderator for Podium Session, Annual Meeting of the American
Urological Association, Anaheim, CA, May, 2007.
44